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ABSTRACT
CALCIUM/DIACYLGLYCEROL- d e p e n d e n t p r o t e i n p h o s p h o r y l a t i o n
IN THE NERVOUS SYSTEM

Katherine Ann Albert
Yale University1988

Calcium/diacylglycerol-dependent protein kinase, most often
referred to as protein kinase C, is of interest to research groups
across many scientific disciplines for two major reasons.

First,

protein kinase C is of general importance in signal transduction because
its second messenger activator, diacylglycerol, is generated by
phosphoinositide metabolism in response to a host of biologically active
molecules.

Second, protein kinase C has been identified as the cellular

receptor for tumor-promoting phorbol esters.

Protein kinase C is of

particular interest to neuroscientists because its highest activity is
in the nervous system.

The studies described in this dissertation were

undertaken to analyze the role of protein kinase C in the nervous
system.

Three different approaches were employed.

First, a major

endogenous substrate for protein kinase C, the 87-kDa protein, was
identified in brain, was purified, and was characterized with respect to
its physicochemical properties and its distribution.

Second, the effect

of phosphorylation by protein kinase C was examined with a nervous
system substrate of known function, namely tyrosine hydroxylase.

Third,
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the regulation of protein kinase C by calcium-binding proteins was
examined.
The 87-kDa protein was identified in bovine brain and was purified
from bovine forebrain supernatant with the use of conventional
chromatographic methods.

The physicochemical properties of the 87-kDa

protein indicated that the molecular weight was 68 kDa, and that the
protein was an extremely elongated monomer.

The 87-kDa protein was

phosphorylated by protein kinase C to a stoichiometry of 2.2 mol

32

P per

mol protein, exclusively on serine residues.
The 87-kDa protein was characterized with respect to its species,
tissue, and subcellular distribution.

A similar protein was present in

monkey, human, rat, mouse, and bovine brain, in Torpedo californica
electric organ, and in a variety of non-neuronal rat and bovine tissues.
The rat protein was of M

4,000-7,000 lower, and was slightly more

acidic, than the bovine protein.

The distribution of the 87-kDa protein

was found to be similar to the distribution of protein kinase C.
Protein kinase C was found to phosphorylate and activate tyrosine
hydroxylase.

The results suggest that protein kinase C and cAMP-

dependent protein kinase phosphorylate the same site(s) on tyrosine
hydroxylase, and activate tyrosine hydroxylase by the same mechanism.
Calmodulin was found previously to inhibit the
calcium/phospholipid-dependent phosphorylation of the 87-kDa protein, in
a crude extract prepared from rat brain synaptosomal cytosol.

In the

present work, rabbit brain calmodulin and some other calcium-binding
proteins were found to inhibit the phosphorylation of the 87-kDa protein
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by protein kinase C, in the purified system.

These results suggest that

protein kinase C may be regulated by calcium-binding proteins.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

To my advisor Paul Greengard

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

ACKNOWLEDGEMENTS

I would like to thank Dr. Paul Greengard, Professor and Head,
Laboratory of Molecular and Cellular Neuroscience, The Rockefeller
University, for his laboratory, where one finds genuine excitement
enhancing the scientific process.

Major thanks are also due to Dr.

Angus N a i m , who made substantive contributions to this thesis, directly
and indirectly.
I would like to thank Drs. Ivar Walaas and James Wang, who carried
out many of the 87-kDa protein distribution experiments, and who were
delightful colleagues.
For the tyrosine hydroxylase experiments, I would like to thank
Dr. Menek Goldstein of the New York University School of Medicine, who
welcomed me to his laboratory, and Elizabeth Helmer-Matyjek, who carried
out most of the experiments with me.
The immunocytochemistry experiments were carried out by Dr.
Charles Ouimet with assistance from Victoria Jeremias.

The

myristoylation experiments were carried out by Dr. Alan Aderem with
assistance from Matthew Keum.
Other colleagues I wish to thank for collaborative efforts and
helpful discussions are: Drs. Otto Walaas, Per Andersen, Susan DeRiemer,
Leonard Kaczmarek, Perry Blackshear, John Haycock, Samuel Gandy, and
Andrew Czernik.

iii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Thanks for technical assistance are due to E. Jane Albert Hubbard,
Barry Swimar, Eric Hubei, Jan Heissinger, Jeanne Holcomb, Elaine
Markland, and Max Cohen.

Extra thanks for technical assistance are due

to Irene Slizys.
I would like to thank the members of my dissertation committee,
Drs. Priscilla Dannies, Robert Roth, Edward Hawrot, and James Jamieson,
for their time and effort in reading and commenting on the thesis.
Finally, I wish to thank my parents Mary S. and Harold G. Albert,
my brother Hal Albert, and my sisters Mary Agnes Jopson and E. Jane
Albert Hubbard, for unflagging support of long duration.

This work was supported by U.S. Public Health Service Grants MH39327, MH-17387, MH-02717, NS-21550, NS-16036, NS-08440, NS-06801, a
contract from the U.S. Air Force School of Aerospace Medicine, and
Training Grant GM-07205.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

TABLE OF CONTENTS

Page

LIST OF FIGURES

vii.

LIST OF TABLES

xi.

LIST OF ABBREVIATIONS

xii.

1. GENERAL INTRODUCTION
Protein Phosphorylation

1.

Diacylglycerol as a SecondMessenger

4.

Protein Kinases

7.

Protein Kinase C

9.

Roles for Protein Kinase C

inCellular Responses

22.

Substrates for Protein Kinase C

26.

Objectives of the Dissertation

30.

2. PURIFICATION AND PHYSICOCHEMICAL CHARACTERIZATION OF THE 87-kDa
PROTEIN
Introduction

32.

Materials and Methods

34.

Results

43.

Discussion

63.

v

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

3. SPECIES, TISSUE, AND SUBCELLULAR DISTRIBUTION OF THE 87-kDa PROTEIN
Introduction

68.

Materials and Methods

68 .

Results

74.

Discussion

87.

4. PHOSPHORYLATION AND ACTIVATION OF TYROSINE HYDROXYLASE BY
PROTEIN KINASE C
Introduction

92.

Materials and Methods

93.

Results

97.

Discussion

106.

5. INHIBITION OF PROTEIN KINASE C BY CALCIUM-BINDING PROTEINS
Introduction

111.

Materials and Methods

113.

Results

116.

Discussion

119.

6 . SUMMARY AND CONCLUSIONS

125.

REFERENCES

130.

vi

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

LIST OF FIGURES

Page
Chapter 1 .
Figure 1.

Protein phosphorylation in the nervous system

3.

Figure 2.

Signal pathway of PI turnover

6.

Chapter 2 .
Figure 3.

Phosphorylation of the 87-kDa protein in rat and

45.

bovine forebrain supernatant
Figure

4.

Chromatography

of step

3 pool

Figure

5.

Chromatography

of step

4 pool on Bio-Gel HTP

49.

Figure

6 . Chromatography

of step

5 pool

on Sephacryl S-400

50.

Figure

7.

of step

6 pool

on FPLC ProRPC

52.

Figure 8 .

Chromatography

on DEAE-Sephacel

NaDodSO^/8% polyacrylamide gel showing the protein

47.

54.

staining pattern at each step of the purification
Figure 9.

NaDodSO^/8% polyacrylamide gel showing the

55.

phosphorylation of the purified 87-kDa protein by
protein kinase C
Figure 10.

Phosphopeptide map of purified 87-kDa protein

57.

phosphorylated by protein kinase C
Figure 11.

Determination of the Stokes radius of 87-kDa protein
by gel filtration

vii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

60.

Figure 12.

Determination of the sedimentation coefficient (son

Z U ,co

)

62.

of the 87-kDa protein by sucrose density gradient
ultracentrifugation
Figure 13.

Time course and stoichiometry of phosphorylation of

64.

purified 87-kDa protein by protein kinase C
Chapter 3 .
Figure 14.

Phosphorylation of endogenous substrates for protein

75.

kinase C in homogenates of monkey, rat, and bovine
brain
Figure 15.

Phosphorylation of endogenous substrates for protein

78.

kinase C in homogenates of bovine tissues
Figure 16.

Heterogeneity of the 87-kDa protein upon isoelectric

81.

focusing
Figure 17.

Immunoprecipitation of the 87-kDa protein from

82.

various bovine tissues
Figure 18.

Immunoblot showing the distribution of the 87-kDa

84.

protein in subcellular fractions from bovine
cerebral cortex
Figure 19.

Electron micrograph of a segment of rat hypothalamus
showing staining of the 87-kDa protein in small
dendrites and glial sheaths

viii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

86.

Figure 20.

Subcellular distribution of immunoprecipitated 87-kDa

88.

protein after treatment of a murine macrophage
preparation with lipopolysaccharide followed by
phorbol 12-myristate 13-acetate
Chapter 4 .
Figure 21.

Phosphorylation of tyrosine hydroxylase by protein

95.

kinase C
Figure 22.

Time course of phosphorylation and activation of

98.

tyrosine hydroxylase by protein kinase C
Figure 23.

Lineweaver-Burk plot of tyrosine hydroxylase activity

101.

as a function of MePH^ concentration, in the presence
and absence of protein kinase C
Figure 24.

Lineweaver-Burk plot of tyrosine hydroxylase activity

102.

as a function of tyrosine concentration, in the
presence and absence of protein kinase C
Figure 25.

Dixon plots of tyrosine hydroxylase activity as a

103.

function of dopamine and 6 -MePH^ concentrations,
in the absence and presence of protein kinase C
Figure 26.

Tryptic/chymotryptic phosphopeptide maps of tyrosine

105.

hydroxylase phosphorylated by the catalytic subunit
of cAMP-dependent protein kinase
Figure 27.

Regulation of tyrosine hydroxylase activity by
protein kinases

ix

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

109.

Chapter 5 .
Figure 28.

Protein stain of the purified preparations of protein

115

kinase C and the 87-kDa protein
Figure 29.

Phosphorylation of the 87-kDa protein by protein

117

kinase C and its inhibition by calmodulin in a
calmodulin-depleted preparation of rat brain cytosol
Figure 30.

Phosphorylation of the 87-kDa protein by protein

118

kinase C, and its inhibition by calmodulin, with
use of purified enzyme and substrate
Figure 31.

Phosphorylation of the two major sites of the 87-kDa

120

protein by protein kinase C, and inhibition of their
phosphorylation by calmodulin
Figure 32.

Phosphorylation of the 87-kDa protein by protein

121

kinase C, and its inhibition by several
calcium-binding proteins
Chapter 6 .
Figure 33.

Feedback interaction between protein kinase C and
calcium

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

128

LIST OF TABLES

Page
Chapter 2 .
Table 1

Purification of the 87-kDa protein from bovine brain

53.

Table 2.

Amino acid composition of the 87-kDa protein

58.

Table 3.

Summary of physical and chemical properties of the

61.

87-kDa protein
Chapter 3 .

Table 4.

Distribution of the 87-kDa protein in bovine tissues

79.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

LIST OF ABBREVIATIONS

ATP

Adenosine 5'-triphosphate

BSA

Bovine serum albumin

CAMP

3',5'-cyclic adenosine monophosphate

cGMP

3',5'-cyclic guanosine monophosphate

DMSO

Dimethylsulfoxide

DTE

Dithioerythritol

EDTA

Ethylenediamine tetra-acetate

EGTA

Ethylene glycol bis(^-aminoethyl ether)-N,N,N',N'tetra-acetic acid

FPLC
IP3

Fast protein liquid chromatography
Inositol-1,4,5-trisphosphate

kDa

Kilodaltons

K.I.U.

Kallikrein Inhibitor Units (for Trasylol)

LPS

Bacterial lipopolysaccharide

M

Apparent molecular weight

r

6-MePH.
4

DL-6-methyl-5,6 ,7,8 -tetrahydropterine

NaDodSO.
4

Sodium dodecyl sulfate

NP-40

Nonidet P-40

OAG

1 -oleoyl-2 -acetyl-glycerol

PAGE

Polyacrylamide gel electrophoresis

xii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

PI turnover

Extracellular signal-mediated hydrolysis and
resynthesis of inositol phospholipids
(initiated as hydrolysis of PIP£ to IP^and
diacyl-glycerol)

PIP2

Phosphatidylinositol 4,5-bisphosphate

PMSF

Phenylme thy1sulfony1fluor ide

Protein kinase C

Calcium/diacylglycerol-dependent protein kinase

Protein kinase M

Proteolytically derived active fragment of protein
kinase C

TFA

Trifluoroacetic acid

xiii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Chapter 1.

GENERAL INTRODUCTION

PROTEIN PHOSPHORYLATION

A major interest of biological science at present is the
elucidation of the mechanisms involved in the transduction of
extracellular signals into biological responses.

Protein phosphoryla

tion has been recognized as one powerful common pathway through which
target cells respond to extracellular signals.

Important early advances

in this research were the first description of a protein kinase (Burnett
and Kennedy, 1954), the demonstration that epinephrine stimulates
glycogenolysis in the liver by increasing the synthesis of cyclic AMP
(cAMP) (Rail et a l .. 1957), the first purification of a protein kinase,
namely phosphorylase b kinase (Krebs et a l .. 1964), and the discovery of
cAMP-dependent protein kinase and its activation as a step in the
sequence of events by which epinephrine regulates glycogen metabolism
(Walsh et al.. 1968).
Cyclic AMP-dependent protein kinase was found to be present in a
wide variety of tissue and phyla of the animal kingdom (Kuo and
Greengard, 1969).

A role for cAMP-dependent protein phosphorylation in

the nervous system was suggested by the presence of a high activity of
the kinase in brain (Miyamoto et a l .. 1969).
These and subsequent findings led to the suggestion that
activation of cAMP-dependent protein kinase is both a necessary and

1
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sufficient step through which cAMP, and those regulatory agents that act
by altering cAMP levels, produce both metabolic and physiological
responses (Kuo and Greengard, 1969; Greengard et a l .. 1971; for reviews
see Nestler and Greengard, 1984; Krebs and Beavo, 1979).

Because of the

discovery of additional second messengers and their corresponding
protein kinases, the original hypothesis has been expanded to state that
a wide variety of extracellular signals produce many of their metabolic
and physiological responses through the regulation of specific protein
kinases (Greengard, 1978, 1987).
The presence of a number of phosphorylation systems in high
concentration in the brain provides evidence for their importance in
nervous tissue (Nestler and Greengard, 1984; Nairn et al.. 1985b).

A

scheme of intracellular protein phosphorylation pathways in the nervous
system is illustrated in Figure 1.

A variety of extracellular signals,

or first messengers, such as neurotransmitters, hormones, or the nerve
impulse itself, produce a variety of biological responses by one or
another of the pathways shown in this scheme.

There are four known

second messengers, namely, cAMP, cyclic GMP (cGMP), calcium, and
diacylglycerol, which achieve many of their effects through activation
of their specific protein kinase(s), namely cAMP-dependent protein
kinase, cGMP-dependent protein kinase, calcium/calmodulin-dependent
protein kinases, and calcium/diacylglycerol-dependent protein kinase
(protein kinase C ) .

All of these kinases phosphorylate serine and

threonine residues on their substrate proteins.

There are also protein

kinases which phosphorylate tyrosine residues on their substrate
proteins, and for which no activators have yet been identified.
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Figure 1. Protein phosphorylation in the nervous system. Extracellular
signals (first messengers) produce specific biological responses in target
neurons via a series of intracellular signals (second, third, and other
messengers).
Second messengers in the brain include cyclic AMP, cyclic GMP,
calcium, and diacylglycerol.
Cyclic AMP and cyclic GMP produce many of
their second messenger actions through the activation of virtually one type
of cyclic AMP-dependent protein kinase and one type of cyclic GMP-dependent
protein kinase, respectively.
The former enzyme exhibits a broad substrate
specificity and the latter a more restricted specificty. Calcium exerts
certain of its second messenger actions through the activation of
calcium/calmodulin-dependent protein kinases. Most calcium/calmodulindependent protein kinases exhibit restricted substrate specificities.
Calcium exerts other actions through a variety of physiological effectors
other than protein kinases. Diacylglycerol with calcium, in the presence of
phosphatidylserine, produces its second messenger action through the
activation of one type of protein kinase, called protein kinase C. These
various cyclic nucleotide-dependent and calcium-dependent protein kinases
phosphorylate proteins specifically at serine and threonine residues. There
is also a class of protein kinases that phosphorylate proteins specifically
at tyrosine residues (protein tyrosine kinases). The activation of
individual protein kinases causes the phosphorylation of specific substrate
proteins in target neurons.
In some cases these substrate proteins, or
third messengers, represent the immediate effector for the biological
response.
In other cases they produce the biological response indirectly
through fourth, fifth, sixth, and other messengers.
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Finally, there are receptors for a variety of growth factors and for
insulin, which are themselves tyrosine kinases.
Direct evidence for the involvement of these protein kinases in
the regulation of specific physiological responses to various first and
second messengers has been obtained, by monitoring the effects of
intracellular injections of the purified protein kinases and specific
protein kinase inhibitors, using electrophysiological recording
techniques.

These studies have demonstrated a causal role for cAMP-

dependent protein kinase (Castelluci et a l .. 1981, 1982; Kaczmarek et
a l .. 1980), cGMP-dependent protein kinase

(Bartfai et al.. 1985;

Paupardin-Tritsch et a l .. 1986), calcium/calmodulin-dependent protein
kinase II (Llinas et a l .. 1985), and protein kinase C (DeRiemer et a l ..
1985; Hammond et a l .. 1987; Hu et a l .. 1987) in the regulation of
specific physiological functions of neurons.

Thus, the results of these

studies provide direct evidence for a relationship between protein
phosphorylation and physiological responses in the nervous system.

DIACYLGLYCEROL AS A SECOND MESSENGER

Hokin and Hokin (1953) first showed that acetylcholine induces a
rapid incorporation of
acid in pancreas.

32

P into phosphatidylinositol and phosphatidic

Later experiments showed that this incorporation

results from the enhanced breakdown and resynthesis of inositol
phospholipids (for reviews see Hokin and Hokin, 1964; Michell, 1975;
Hawthorne and Pickard, 1979; Irvine et a l .. 1982; Berridge, 1987).
Durell et a l . (1969) suggested a potential role for this response in
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receptor functions, and Michell (1975) postulated that the phospholipid
breakdown might open a calcium gate.

In 1983, Berridge and his

coworkers (Streb et al.. 1983; Berridge and Irvine, 1984) demonstrated
that one of the two direct products of phosphatidylinositol 4,5bisphosphate (PIP2 ) hydrolysis, namely inositol-1,4,5-trisphosphate
(IP^), serves as a mediator for calcium mobilization from an
intracellular compartment.

Nishizuka and his coworkers demonstrated

that the other product of PIP2 hydrolysis, namely 1 ,2-diacylglycerol,
activates protein kinase C; they also demonstrated that this protein
phosphorylation system is separate from (but often acts synergistically
with), the calcium signaling pathway in the control of various cellular
functions (Takai et a l .. 1979; Kishimoto et a l .. 1980; Mori et a l ..
1980; Kawahara et a l .. 1980; Sano et al .. 1983).

Therefore, a key

feature of the inositol lipid signaling system is that both products of
PIP2 hydrolysis function as second messengers.

Figure 2 depicts this

bifurcating signal pathway of PI turnover.
Receptor-mediated hydrolysis of inositol phospholipids (PI
turnover) has recently been appreciated to be a common mechanism for the
transduction of various extracellular signals into the cell.
Extracellular messengers which achieve their effects via PI turnover
include certain hormones, neurotransmitters, antigens, growth factors,
and many other biologically active substances (detailed lists of these
stimuli may be found in Berridge, 1984; Berridge and Irvine, 1984;
Downes and Michell, 1985; Hokin, 1985; Nahorski, 1986).

In neural

tissues (for review see Fisher and Agranoff, 1987), K+ -induced
depolarization in the presence of calcium results in PI turnover.
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Figure 2. This scheme depicts the production of the protein
kinase C activator diacylglycerol in the bifurcating signal pathway of
PI turnover.
The transduction unit within the plasma membrane consists
of three main components: a receptor that detects the oncoming signal,
the G protein G that serves to couple the receptor to the third
component, and ?he phosphoinositidase responsible for cleaving the lipid
precursor. When an agonist occupies the receptor, it activates G ,
which then binds GTP as part of the reaction leading to the stimufation
of phosphoinositidase, which hydrolyzes PIP. into the two second
messengers diacylglycerol and IP,. Diacylglycerol activates protein
kinase C, and IP^ serves as a mediator for calcium mobilization from an
intracellular compartment.
Therefore, a key feature of this signaling
system is that both products of PIP^ hydrolysis function as second
messengers.
Both second messengers can be metabolized rapidly back to
phosphatidylinositol.
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Nervous system receptors demonstrated to be coupled to PI turnover
include M^ and

muscarinic cholinergic,

adrenergic,

histaminergic, 5-HT2 and 5-HT^c serotonergic, and glutaminergic;
receptors purported to be coupled to PI turnover include those for
substance K, neurotensin, cholecystokinin, substance P, vasopressin,
bradykinin, TRH, vasoactive intestinal peptide, and angiotensin;
receptors not coupled to PI turnover include
serotonergic, f } - adrenergic,

histaminergic, 5-HT^

-adrenergic, nicotininc cholinergic, and

GABAergic (see Fisher and Agranoff, 1987).
The transduction unit within the plasma membrane consists of three
main components (for review see Berridge, 1987): 1. the receptor that
detects the oncoming signal, 2. a G protein (G^) that serves to couple
the receptor to the third component, and 3. the phosphodiesterase
responsible for cleaving the lipid precursor.

In order to avoid

confusion with the nomenclature employed in the cAMP field, where
phosphodiesterase is used to describe the enzyme that degrades cAMP to
AMP, Downes and Michell (1985) have introduced the term phos
phoinositidase to describe the enzyme that hydrolyzes PIP^.

PROTEIN KINASES

The effects of cAMP are achieved through activation of cAMPdependent protein kinase, which phosphorylates many substrate proteins.
Some, but not all, of the effects of cGMP are achieved through
activation of cGMP-dependent protein kinase, which phosphorylates a
number of specific substrate proteins.
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The second messenger actions of calcium are more complex.

A few

of the second messenger actions of calcium are achieved through
regulation of physiological effectors other than protein kinases (see
Chapter 5).

However, it appears that many of the second messenger

actions of calcium are achieved through activation of the two subclasses
of calcium-dependent protein kinases, namely calcium/calmodulindependent protein kinases and protein kinase C.
The existence of calcium/calmodulin-dependent protein kinase(s)
was independently reported by different research groups in 1978
(Dabrowska et a l ., 1978; Schulman and Greengard, 1978; Yagi et a l ..
1978; Cohen et a l .. 1978; Perry et a l .. 1978).

A number of

calcium/calmodulin-dependent protein kinases have subsequently been
identified in various tissues; these kinases include phosphorylase
kinase (Cohen et a l .. 1978); myosin light chain kinase (Dabrowska, 1978;
Yagi et a l .. 1978; Nairn and Perry, 1979); calcium/calmodulin-dependent
protein kinase I (Nairn and Greengard, 1987), which phosphorylates site
I on synapsin I, a synaptic vesicle-associated protein (De Camilli et
a l - . 1983a,b; Huttner et a l .. 1983); calcium/calmodulin-dependent
protein kinase II (McGuinness et a l .. 1983; Bennett et a l .. 1983;
McGuinness et a l .. 1985), which phosphorylates site II on synapsin I,
and which appears to be an isozyme of a family of related multifunc
tional enzymes which phosphorylate several proteins, including glycogen
synthase, microtubule-associated protein 2 , and tyrosine hydroxylase
(McGuinness et a l .. 1983; Bennett et a l .. 1983; McGuinness et a l .. 1985;
Ahmad et a l .. 1982; Fukunaga et al.. 1982; Yamauchi and Fujisawa, 1983;
Payne et al.. 1983; Gorelick et a l .. 1983; Goldenring et a l .. 1983;
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Kuret and Schulman, 1984); and calcium/calmodulin-dependent protein
kinase III ( N a i m et a l .. 1985a), which phosphorylates a protein which
has recently been shown to be identical to elongation factor 2 (Nairn
and Palfrey, 1987).

Most of the calcium/calmodulin-dependent protein

kinases appear to have a limited substrate specificity, i.e. each kinase
phosphorylates one or two proteins, with the notable exception of
calcium/calmodulin-dependent protein kinase II, which has a somewhat
broader substrate specificity.

PROTEIN KINASE C

The other subclass of calcium-dependent protein kinase, protein
kinase C (for recent reviews see Woodgett et a l .. 1987; Kikkawa and
Nishizuka, 1986; Niedel and Blackshear, 1986), is activated by the
second messengers calcium and diacylglycerol and requires the presence
of phosphatidylserine for activity.
Identification of protein kinase C .

The initial major discoveries

concerning protein kinase C were all accomplished by Nishizuka and
colleagues, including its description as a protein kinase activatable in
vitro by proteolysis (Inoue et a l .. 1977; Takai et al.. 1977); the
demonstration that the kinase can be stimulated by calcium and acidic
phospholipids (Takai et a l .. 1979b); the discovery that diacylglycerol
stimulates the activity of the kinase by increasing its affinity for
calcium and phospholipids (Takai et a l .. 1979a; Kishimoto et al.. 1980);
and the discovery that tumor-promoting phorbol esters can activate the
kinase by substituting for diacylglycerol (Castagna et al.. 1982).
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Protein kinase C was soon found by a number of researchers to be the
major, and perhaps the only, tumor-promoting phorbol ester receptor
(Ashendel et al.. 1983a,b; Niedel et a l .. 1983; Leach et a l .. 1983;
Sando and Young, 1983; Kikkawa et al.. 1983b).

The discovery of protein

kinase C as the major phorbol ester receptor will allow the biochemical
effects of tumor promotion to be probed in greater detail (for reviews
see Nishizuka, 1984a,b; Ashendel,1985; Castagna, 1987).
Protein kinase C is broadly distributed among the tissues of
vertebrates and throughout the phyla of the animal kingdom (Kuo et a l ..
1980; Minakuchi et a l .. 1981).

The enzyme was first partially purified

from bovine heart (Wise et a l .. 1982), then was purified to homogeneity
from tissues in which it is more abundant, namely rat brain (Kikkawa et
al.. 1982) and pig spleen (Schatzman et a l .. 1983).

The enzyme is most

often isolated from brain (Kikkawa et al.. 1983a, 1986; Le Peuch et a l ..
1983; Parker et a l .. 1984a; Walsh et a l .. 1984; Wolf et a l .. 1984; Jeng
et a l .. 1986; Woodgett and Hunter, 1987) or adrenal gland (Uchida and
Filburn, 1984).

The purified enzyme from these preparations appears as

a single or double protein staining band of

77,000-83,000 upon

NaDodSO^ polyacrylamide gel electrophoresis (PAGE), behaves as a monomer
of 77,000 upon sedimentation analysis, and behaves as a monomer of
87,000

upon gel filtration chromatography; its pi is about 5.6 (Kikkawa

et a l .. 1982; Wise et a l .. 1982).
between 7.5 and 8 , and its K

m

The pH optimum for its activity is

for ATP is about 10 yM (Kikkawa et al..
------

1982; Wise et al.. 1982).
Activation of protein kinase C .

The activation of protein kinase

C by a cation is specific for calcium (Takai et a l .. 1979b; Wise et a l ..
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1982).

Studies of the in vitro activation of protein kinase C by

phospholipids and diacylglycerol in aqueous buffers are complicated by
solubility issues.

In studies with sonicated phospholipids, protein

kinase C can be activated in the presence of calcium by acidic
phospholipids, preferentially phosphatidylserine, while basic
phospholipids are ineffective (Takai et a l .. 1979b; Wise et a l .. 1982;
Kaibuchi et a l .. 1981).

Diacylglycerol alone does not activate protein

kinase C, but in the presence of phosphatidylserine, diacylglycerol
lowers the calcium requirement of the enzyme from approximately 100 pM
to less than 1 /iM (Takai et a l .. 1979b; Kishimoto et a l .. 1980).

In the

presence of diacylglycerol and 2 fi M calcium, phosphatidylserine is the
only activating phospholipid (Kaibuchi et a l .. 1981).

Other lipophilic

compounds, e.g. unsaturated fatty acids, have been reported to
substitute for phospholipids (Ohkubo et a l .. 1984;

McPhail

et a l ..1984;

Horn et a l .. 1985; Murakami and Routtenberg, 1985;

Hansson

et a l ..1986;

Shoyab, 1985; Wightman and Raetz, 1984), but their

role in

the

physiological activation of protein kinase C is unclear.

More recent

studies with defined, stable vesicles of phosphatidylserine:
phosphatidylcholine (1:4) (Boni and Rando, 1985) and with defined
phosphatidylserine-.Triton X-100 mixed micelles (Hannun et a l .. 1985,
1986), have shown that in the presence of calcium (and
phosphatidylserine), there is close to an absolute dependence on
diacylglycerol for activity.
Sn-1,2-diacylglycerols stereospecifically activate protein kinase
C (Takai et a l .. 1979a; Kishimoto et a l .. 1980; Rando and Young, 1984;
Couturier et a l .. 1984).

The 3-OH group and 1,2-carbonyls are required
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for activation (Cabot and Jaken, 1984; Ganong et a l .. 1986).

A long-

chain fatty acid is required for at least one (either) of the 1,2
positions (Mori et a l . . 1982), with activity increasing from 3 to 11
carbons (Hannun et a l .. 1986).

Diacylglycerols which have long enough

fatty acid chains to activate protein kinase C, but whose chains are not
so long as to have solubility problems when used in an intact cell
system, are called permeant diacylglycerols.

l-01eoyl-2-acetyl-glycerol

(OAG) (Mori et a l .. 1982) and sn-l,2-dioctanoylglycerol (DiCg) (Ganong
et a l .. 1986) are often used.

Diacylglycerol increases the affinity of

the enzyme for phospholipid 2-3-fold and, as mentioned above, decreases
the

for calcium about 100-fold (Kishimoto et al.. 1980; Wise et a l ..

1982; Hannun et a l . . 1986).

Conversely both phospholipid and calcium

increase the affinity of the enzyme for diacylglycerol (Hannun et al..
1986).

A model has been proposed (Bell, 1986) in which a "primed"

(protein kinase C)^(phosphatidylserine)^ (calcium)^ complex is formed,
to which one molecule of diacylglycerol binds to activate the enzyme.
Therefore, active protein kinase C appears to exist as a quarternary
complex comprising the enzyme, phosphatidylserine, calcium, and
diacylglycerol.
Protein kinase C can also be activated by proteolysis.

Protein

kinase C was initially isolated as a protease-activated protein kinase
(Takai et al.. 1977).

Incubation with calcium-dependent neutral

protease (calpain I), or trypsin, generates a 50 kDa catalytic fragment,
called protein kinase M, that is no longer dependent on calcium or
phospholipid for activity (Kishimoto et a l .. 1983).
proteolysis destroys activity.

Sustained

Proteolytic cleavage is enhanced in the
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presence of calcium and diacylglycerol, which suggests that the active
form of the enzyme is more susceptible to proteolysis (Kishimoto et a l ..
1983).

A 35 kDa regulatory domain of protein kinase C can also be

generated upon proteolysis (Hoshijima et a l .. 1986; Huang and Huang,
1986; Woodgett et a l .. 1987).
Like other protein kinases, protein kinase C undergoes an
autophosphorylation reaction in vitro in the presence of magnesium, ATP,
calcium, phosphatidylserine, and diacylglycerol (Kikkawa et a l .. 1982;
Woodgett and Hunter, 1987; Huang et a l .. 1986a).

Both serine and

threonine residues are labeled (Kikkawa et a l .. 1982; Huang et a l ..
1986a).

Protein kinase C autophosphorylation has a K

for ATP (1.5 fiW)

lower than that for the phosphorylation of exogenous substrates, and the
reaction appears to be intramolecular (Huang et a l .. 1986a).

The

autophosphorylated enzyme still depends on calcium and phospholipid for
maximal activity; however, the autophosphorylated kinase has a lower K
for calcium and a higher affinity for the binding of phorbol ester than
the nonphosphorylated form (Huang et a l .. 1986a).

These findings

suggest that autophosphorylation of protein kinase C may be important in
the regulation of the enzymic activity subsequent to signal
transduction.
Translocation of protein kinase C .

Upon subcellular fractionation

of protein kinase C from rat brain in the presence of EGTA and EDTA,
about 40% of protein kinase C activity is found in the soluble fraction,
and 60% is found in the particulate fraction, although the particulate
kinase can be detected only after treatment of the particulate fraction
with Triton X-100 (Kikkawa et a l .. 1982).

The significance of this
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detergent-solubilized fraction of protein kinase C is unknown.

In the

presence of calcium, the EGTA-solubilized fraction of the kinase is
found to be associated with the particulate fraction (Takai et a l ..
1979b; Takai et a l .. 1979c).

Experiments with inside-out erythrocyte

vesicles showed that calcium controls the binding of protein kinase C to
membranes, that phorbol esters and diacylglycerol control both binding
and activity, and that calcium and phorbol esters each potentiate the
other's ability to stabilize the association of the kinase to membranes
(Wolf et a l .. 1985a,b).

Therefore, it appears that part of the

activation process involves the binding of protein kinase C to
membranes.

Although the calcium-mediated association of the cytosolic

fraction of protein kinase C with membranes or phosphatidylserine
vesicles is reversible by the removal of calcium, the enzyme is not
easily removed when it is activated by diacylglycerol or phorbol ester
(see Bell, 1986); release of the enzyme from membranes occurs by a
process that is enhanced by ATP and magnesium (Wolf et a l .. 1985b).
Phorbol esters and permeant diacylglycerols applied extracellularly result in protein kinase C activation (Castagna et a l . . 1982;
Kaibuchi et a l .. 1983; Ebeling et a l .. 1985), and produce translocation,
i.e. decreases in cytosolic and increases in particulate protein kinase
C (Kraft et a l .. 1982; Kraft and Anderson, 1983; McCaffrey et a l .. 1984;
Shoji et a l .. 1986).

In contrast, several different patterns of protein

kinase C localization have been seen in response to extracellular
signals which activate phosphatidylinositol 4,5-bisphosphate (PIP2)
hydrolysis, including translocation from soluble to particulate
fractions (Hirota et a l .. 1985; Farrar and Anderson, 1985; Farrar et
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a l .. 1985; Nel et a l .. 1986; Fearon and Tashjian, 1985; for review see
Anderson et al.. 1985), "reverse" translocation from membranes to the
soluble fraction (Vilgrain et a l .. 1984; Costa-Casnellie et a l .. 1985),
and no apparent change (Halsey et a l .. 1986).

The molecular mechanisms

of these diverse responses remain to be determined.
Another interesting question is the cellular site(s) of attachment
of protein kinase C to membranes.

The phospholipid composition of

membranes may determine which cellular membranes can support binding of
protein kinase C.

Since the inner leaflet of the plasma membrane is

particularly rich in acidic phospholipids, and other membranes contain
greater proportions of phosphatidylcholine, one might predict that the
enzyme will exhibit a higher affinity for the former (Woodgett et a l ..
1987), which is also the sight of agonist-induced diacylglycerol
production.

However, Takai et a l . (1979c) found that intracellular

membranes could also activate protein kinase C, and after subcellular
fractionation, phorbol ester binding (Dunphy et a l .. 1981) and protein
kinase C activity (Kikkawa et al.. 1982) were found in all particulate
fractions.

In addition, studies of the distribution of fluorescent

derivatives of phorbol esters have suggested that active phorbol esters
are taken up rapidly by the cells and stain intensely the entire
cytoplasm, while the nucleus is unstained (Liskamp et al.. 1985).
Finally, recent experiments with immunofluorescent microscopy with
antibodies directed against protein kinase C have suggested that there
are differences in the responses of different cell types to phorbol
esters, in terms of intracellular localization of the immunoreactive
kinase (Halsey et al.. 1986; Shoji et al.. 1986).

Therefore, it may be
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that in vivo localization and activation of protein kinase C at any one
time depends on such factors as intracellular calcium concentration,
diacylglycerol concentration, and the phospholipid composition of the
cellular membranes.
Down-regulation of protein kinase C .

A property of the phorbol

ester receptor related to translocation is down-regulation in response
to the treatment of certain intact cells with phorbol ester (Shoyan and
Todaro, 1980; Jaken et a l .. 1981; Solanki et a l .. 1981; Collins and
Rozengurt, 1982; Yamasaki et a l .. 19S2).

Cells in which the receptor

has been down-regulated are refractory to further stimulation by phorbol
esters or other agonists of protein kinase C.

This property has been

exploited to determine the involvement of protein kinase C in different
cellular processes (see e.g. Rozengurt et a l .. 1983; Coughlin et a l ..
1985) .

The mechanism for down-regulation has recently been elucidated,

with use of antibodies to protein kinase C (Ballester and Rosen, 1985;
Woodgett et a l .. 1987).

The protein kinase which has been translocated

and activated has a much shorter half-life than the kinase in the
resting cell (1-5 h vs. longer than 24 h ) , probably due to an increased
rate of degradation, since down-regulation is inhibited by leupeptin
(see Woodgett et a l .. 1987).

There is no decrease in protein kinase

synthesis or mRNA levels (see Woodgett et a l .. 1987) in cells treated
with TPA.

Persistent stimulation with phorbol ester causes newly

synthesized protein kinase C to move to the membrane and be subject to
the faster degradation rate.
Inhibition of protein kinase C .

The activity of protein kinase C

can be inhibited by a variety of compounds.

1. Inhibitors of
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phospholipid binding.

One class of inhibitors interferes with

phopholipid binding to protein kinase C.

Within this class, there is a

subset of inhibitors which are not specific because they are all potent
inhibitors of other cellular functions, including calcium/calmodulindependent protein phosphorylation.

These include members of the

phenothiazine drug family (Mori et al.. 1980; Schatzman et al .. 1981;
Uratsuji et a l .. 1985), W7 (Tanaka et a l .. 1982), and R-24571 (Mazzei et
a l . . 1984).

Another subset of inhibitors which interact with

phospholipids include surface active polypeptides such as marine worm
cytotoxin AIV (Kuo et a l .. 1983), cobra cytotoxin 1 (Kuo et al.. 1983),
the antibiotic polymixin B (Mazzei et a l .. 1982), gossypol, which is
also an adenylate cyclase inhibitor (Kimura et a l .. 1985), and
tamoxifen, which is also a cAMP phosphodiesterase inhibitor (O'Brian et
a l .. 1985).

Toxicity restricts the usefulness of this subset of

compounds in vivo.

Another compound which interferes with phospholipid

binding is sphingosine (Hannun et a l .. 1986), the specificity and
usefulness of which are still being investigated.
2.
ATP.

Competitors of ATP.

Another class of inhibitors competes with

A series of isoquinolinesulphonamide compounds have been reported

to inhibit several protein kinases with different selectivities (Hidaka
et a l .. 1984).

For example, H -8 inhibits cyclic nucleotide-dependent

protein kinases 15-30-fold more potently than protein kinase C, while H7 inhibits protein kinase C with a similar potency to the other protein
kinases (Hidaka et a l .. 1984).

Unfortunately, in vitro none of the

compounds selectively inhibit protein kinase C.
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3. Synthetic peptides.

Protein kinase C phosphorylates a number

of synthetic peptides corresponding to phosphorylation site sequences of
substrates (O'Brian et a l .. 1984; Ferrari et a l .. 1985; Kishimoto et
a l .. 1985; Turner et al.. 1985; Woodgett et a l .. 1986).

Substitution of

the phosphorylated residue in such peptides with a non-phosphorylatable
residue such as alanine results in the formation of selective but rather
weak inhibitors of the enzyme which are competitive with respect to
substrates (O'Brian et al.. 1984; Su et a l .. 1986).
4. Staurosporine.

The most potent inhibitor thus far described is

staurosporine, an antifungal microbial alkaloid (Tamaoki et a l .. 1986),
but this compound also potently inhibits cAMP-dependent protein kinase
and is toxic to cell growth.
5. Calcium-binding proteins.

Finally, protein kinase C activity

can be inhibited by certain calcium-binding proteins.

The first

observation of inhibition by calmodulin of calcium/phospholipiddependent protein phosphorylation was made in the nervous system by Wu
et al. (1982).

Chapter 5 of this thesis presents further characteriza

tion of this inhibition of protein kinase C by calcium-binding proteins,
with use of purified components.

There have been other reports of

inhibition of protein kinase C by calmodulin (Saitoh and Dobkins, 1986),
by troponin C (Mazzei and Kuo, 1984), and by SlOOb protein (Baudier et
a l .. 1986).

A novel calcium-binding protein of M

17,000 that inhibits

protein kinase C activity has been purified from brain and characterized
extensively (McDonald and Walsh, 1985a,b,1986; McDonald et a l .. 1987).
There have also been reports of inhibition of protein kinase C activity
by unidentified low molecular weight proteins isolated from brain
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(Schwantke and LePeuch, 1984) and from stomach (Holian et a l .. 1986).
This topic is discussed in greater detail in Chapter 5.
Isozvmes of protein kinase C .

The existence of multiple forms of

protein kinase C was found recently by a number of research groups, with
use of complementary DNA cloning in rat brain (Ono et a l .. 1986; Knopf
et a l .. 1986), bovine brain (Parker et a l .. 1986; Coussens et a l ..
1986), and rabbit brain (Ohno et a l .. 1987); and with use of biochemical
techniques in rat brain (Huang et a l .. 1986b; Woodgett and Hunter,
1987).

At least three different cDNA clones have been identified (for

review see Carpenter et a l .. 1987), and additional forms of protein
kinase C may be generated by alternate splicing of mRNA (Ohno et a l ..
1987).

Regions of similarity exist in the reported sequences, such that

the distribution of conserved residues allows the division of the
protein into four conserved (C1-C4) and five variable (VI-V5) regions
(Carpenter et a l .. 1987).

C3 and C4, in the carboxy-terminal region of

the protein, have the greatest homology with cAMP- and cGMP-dependent
protein kinases, and there is a likely cleavage site for calpain I,
which would divide the protein into an amino-terminal regulatory domain
and a carboxy-terminal catalytic domain (Carpenter et a l .. 1987)

Other

than sequence, the only clear difference recognized among these forms so
far has been distribution, with one type found specifically in brain, a
second type found in all tissues examined, and a third type found in
many tissues, but not in as widespread a distribution as the second type
(Huang et a l .. 1986b; Ohno et a l .. 1987; Brandt et a l .. 1987; Huang et
al.. 1987).
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Distribution of protein kinase C within brain.

Immunological and

phorbol ester binding studies of the regional and subcellular
distribution of protein kinase C within the brain have yielded
conflicting results.

Studies with polyclonal antisera found that the

enzyme was distributed broadly in different brain regions, but the
enzyme was found to be concentrated in granule cells in the hippocampus,
in mossy fibers, Golgi II neurons, and Purkinje neurons in the
cerebellum, and in axons and cells resembling oligodendroglia in white
matter regions (Girard et a l .. 1985; Wood et a l .. 1986).

These studies

also found the enzyme to be concentrated presynaptically in nerve
terminals, with little staining post-synaptically, and to be present
inside the nucleus (Girard et a l .. 1985; Wood et a l .. 1986).

A study

using phorbol ester binding found discrete binding sites primarily
associated with neurons; evidence was presented for localization to
intrinsic neurons of the cortex and hippocampus, terminals of the
striatonigral projection, a projection to the molecular layer of the
dentate gyrus, and to dendrites of Purkinje cells; thus, this study
showed binding primarily associated with neurons, within the cerebellum
within Purkinje cells, and subcellularly within terminals and dendrites
(Worley et al.. 1986).

These results were in general agreement with a

regional distribution of protein kinase C measured biochemically (Walaas
et a l . . 1983a,b), with regional phorbol ester binding measured in
homogenates (Nagle et a l .. 1981), and with a preliminary study of
phorbol ester binding by Nagle and Blumberg (1983).

In another study

with monoclonal antibodies, the authors postulated that their antibodies
recognized only the nervous tissue-specific isozyme of protein kinase C
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(Kitano et a l .. 1987).

They found the enzyme to be primarily in nervous

tissue; in cerebellum, it was primarily in Purkinje cells; and in
Purkinje cells, it was present throughout the cytoplasm, including
dendrites and axons, but was poorly represented in the cell nucleus
(Kitano et a l .. 1987).

Thus, these results were consistent with those

of Worley et al. (1986).

Finally, a study using a series of monoclonal

antibodies found three distinct antibody-staining patterns; one antibody
excusively labeled astroglial elements, including astrocytes, tanycytes,
and cerebellar radial glia; another exclusively labeled neural cells,
including cortical and hippocampal pyramidal dendrites and Purkinje
cells of the cerebellum; a third stained more limited regions including
thalamic neurons, and astroglial structures in brain, spinal cord, and
cerebellum (Mochly-Rosen et a l .. 1987).

It is possible that these

staining patterns reflect isozymes of protein kinase C (Mochly-Rosen et
a l .. 1987).

Huang et al. (1987) have reported that one isozyme is

highly concentrated in cerebellum, hippocampus, and amygdala, another is
highly concentrated in caudate, frontal and motor cerebral cortices,
substantia nigra, and the thalamus, and a third is highly concentrated
in the in olfactory bulb.

In summary, there is disagreement about the

distribution of protein kinase C in neurons vs. neurons and glia, about
the exclusive distribution in Purkinje vs. other cells in the
cerebellum, and about the presence or absence of protein kinase C in
nuclei and in post-synaptic elememts.

Further study will be required to

resolve these questions.
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POSSIBLE ROLES FOR PROTEIN KINASE C IN CELLULAR RESPONSES

Since protein kinase C is activated by tumor-promoting phorbol
esters, protein kinase C has been postulated to have a role in all of
the previously known effects of phorbol esters, such as carcinogenesis,
mitogenesis, cell differentiation, cell morphology, gene expression and
cell proliferation.

In many of these cases, further experimentation

with permeant diacylglycerols will be necessary as the next step for
elucidating the role of protein kinase C in these processes (Woodgett et
al.. 1987).
Synergism with Calcium for Secretion.

Under appropriate

conditions, protein kinase C activation and calcium mobilization can be
induced selectively and independently by the application of a permeant
diacylglycerol or phorbol ester for the former and a calcium ionophore
such as A23187 or ionomycin for the latter.

By using this procedure it

has been shown that the two signal pathways are both essential to elicit
full cellular responses.

The role of protein kinase C in stimulus-

response coupling was first demonstrated for the release of serotonin
from platelets (Kaibuchi et al .. 1983) and was subsequently shown for
release reactions from a wide variety of cell types (for list see
Kikkawa and Nishizuka, 1986), including neural tissues, e.g.
catecholamine secretion from adrenal medulla (Knight and Baker, 1983;
Brocklehurst et a l .. 1985; Houchi et a l .. 1985; Pocotte et al.. 1985),
acetylcholine release from ileal nerve endings (Tanaka et a l .. 1984) and
caudate nucleus (Tanaka et a l .. 1986), dopamine release from PC12 cells
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(Pozzan et a l .. 1984) and neurons (Zurgil and Zisapel, 1985), and
transmitter release from a neuromuscular preparation (Publicover, 1985).
Modulation of Membrane Functions.

It has been proposed that

protein kinase C plays a role in extrusion of calcium immediately after
its mobilization into the cytosol, and that calcium-transport ATPase is
a possible target.

Studies with many cell types, including vascular

smooth muscle and platelets, have shown that when receptors are
stimulated, the appearance of calcium is transient (Morgan and Morgan,
1982; Johnson et a l . . 1985; see Berridge, 1987).

In various cell types,

the cytosolic calcium concentration is frequently decreased by the
addition of phorbol ester (Sagi-Eisenberg et a l .. 1985; Drummond, 1985;
Tsien et a l .. 1982; Moolenar et a l .. 1984; Lagast et al.. 1984; Albert
and Tashjian, 1985).

From experiments with sarcoplasmic reticulum

preparations from heart, it has been proposed that calcium-transport
ATPase is activated by the addition of protein kinase C (Limas, 1980;
Iwasa and Hosey, 1984; Movsesian et al.. 1984).

In contrast, this

protein kinase may take part in the enhancement of calcium entry in
invertebrates, since microinjection of protein kinase C into bag cell
neurons from Anlvsia enhances the voltage-sensitive calcium current
(DeRiemer et al.. 1985); and the kinase has been shown to decrease a
calcium current in Hermissenda (Hammond et a l .. 1987).
Similarly, a role for protein kinase C in activating sodiumtransport ATPase in peripheral nerve has been suggested (Greene and
Lattimer, 1986).

The Na+/H+ exchange protein appears to be another

target that is activated by phorbol ester or by permeant diacylglycerol
and, thus, protein kinase C may function to regulate cytoplasmic pH
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(Burns and Rozengurt, 1983; Rosoff et a l .. 1984; Moolenar et a l .. 1984;
Besterman et al.. 1985).

An additional example is obtained with

photoreceptor cells of Hermissenda (Farley and Auerbach, 1986) and rat
hippocampal pyramidal neurons (Baraban et al .. 1985).

In these cells,

treatment with phorbol ester or permeable diacylglycerol, as well as
intracellular injection of protein kinase C, reduces calcium-dependent
K+ conductance.

Thus, protein kinase C has been proposed to play a role

in the expression of plasticity, particularly in hippocampal neural
activity (Routtenberg et a l .. 1985; Akers et a l .. 1986; Reymann et a l ..
1985) and learning in Hermissenda (Farley and Auerbach, 1986).
Negative feedback control.

A major function of protein kinase C

appears to involve negative feedback control.

The application of

phorbol ester can inhibit the subsequent response to occupation of
receptors that are coupled to PI turnover, and this inhibition has been
reported to occur in many cell types (for reviews see Kikkawa and
Nishizuka, 1986; Nishizuka, 1986; Woodgett et a l .. 1987), including
pituitary cells, hippocampal slices, PC12 cells, and astrocytoma cells.
The biochemical basis of this negative feedback control remains to be
clarified.

The discovery that hormonal activation of phospholipase C is

mediated through a G protein, termed G^ for phospholipid, introduces a
potential target for regulation by analogy with the G^ and Gg proteins
of adenylate cyclase (Cockroft and Gomperts, 1985; Litosch et a l ..
1985).

The negative regulation by protein kinase C also extends to

receptors of other signaling systems.

For example, protein kinase C

phosphorylates the EGF receptor with a concomitant decrease in both its
tyrosine kinase activity and growth factor binding activity (see below).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

25

Interaction between signaling systems.

Cellular responses may be

divided into several modes (see Nishizuka, 1986) based on the
interaction between the class of receptors that result in the generation
of cAMP and the class of receptors that result in PIP2 hydrolysis.

In

one control system the two classes of receptor counteract each other,
whereas in another control system the two classes potentiate each other.
In cell types such as platelets, neutrophils, and lymphocytes, the
signals that induce PIP2 hydrolysis activate release reactions and
cellular proliferation, but the signals that produce cAMP usually
antagonize such activation.

In these cells the signal-induced PI

turnover and subsequent events leading to cellular proliferation are all
blocked by cAMP.

In another group of cells, such as avian erythrocytes,

Leydig cells, and glioma C6 cells, protein kinase C inhibits and
desensitizes the adenylate cyclase system.

In several other cell types,

including pinealocytes, pituitary cells, and lymphoma S49 cells, protein
kinase C potentiates cAMP production.

There is as yet no obvious

example of a tissue in which cAMP potentiates signal-induced PI
turnover.

For the most part the molecular mechanisms for these negative

and positive actions between the cyclic nucleotide and phosphoinositide
pathways remain to be elucidated.

As mentioned above, the discovery

that hormonal activation of phospholipase C is mediated through a G
protein introduces a potential target for regulation (Cockroft and
Gomperts, 1985; Litosch et al.. 1985).
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SUBSTRATES FOR PROTEIN KINASE C

In order to understand the mechanisms of responses to activation
of protein kinase C, the proteins that are phosphorylated by this kinase
must be identified.

This has not been an easy task since the purified

enzyme phosphorylates many potential substrates presented to it in
v itro.

Hence a long list of substrates has been created which includes

proteins of a variety of functions, subcellular locations, and
structures.

The reported substrates for protein kinase C may be divided

into three categories: 1. substrates for protein kinase C in vitro. 2.
proteins whose phosphorylation is stimulated by phorbol ester in vivo,
and 3. proteins phosphorylated by protein kinase C in vitro and whose
phosphorylation is stimulated by phorbol ester in vivo (for detailed
lists see Woodgett et al. (1987)).
1. The reported substrates for protein kinase C in vitro include a
number of enzymes, such as myosin light chain kinase (Ikebe et a l ..
1985; Nishikawa et al.. 1985) and calcium-activated neutral protease
(Hincke and Tolnai, 1986); a number of cytoskeletal elements, including
microtubule associated protein-2 (MAP-2) (Tsuyama et a l .. 1986); and a
number of proteins whose phosphorylation was found on NaDodSO^/PAGE in
preparations from a number of tissues, e.g. a 36 kDa protein from lung
(Malkinson et a l .. 1985), and a 36 kDa protein from pituitary secretory
granules (Turgeon and Cooper, 1986).
2. Proteins whose phosphorylation is stimulated by phorbol ester
in vivo include a number of identified proteins, such as the p56 protein
tyrosine kinase (Casnellie and Lamperts, 1986), ribosomal protein S6
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(LePeuch et a l .. 1983; Blenis et a l .. 1984; Trevillyan et a l .. 1984;
Padel and Soling, 1985; Parker et a l .. 1985; Trevillyan et al.. 1985),
and a number of proteins whose phosphorylation has been identified by
NaDodSO^/PAGE, e.g. 83 kDa, 75 kDa, 47 kDa, 43 kDa, and 21 kDa proteins
from primary rat neurons (Burgess et a l .. 1986).

A major caveat of this

group of proteins is that the phosphorylated proteins may be substrates
for kinases activated by protein kinase C rather than substrates for
protein kinase C itself.
3.

Thus far, there are relatively few proteins that are

phosphorylated by protein kinase C in vitro and whose phosphorylation is
stimulated by phorbol ester in vivo.

Two of them, the 87-kDa protein

and tyrosine hydroxylase, are the subjects of Chapters 2,3, and 4 of
this thesis.
The 87-kDa protein was first described as a component of rat brain
synaptosomes and was found to be phosphorylated in response to
depolarization-induced calcium influx (Wu et a l .. 1982).

Since that

time, a number of studies have demonstrated phosphorylation of the 87kDa protein in response to stimulators of PI turnover and activators of
protein kinase C (see Chapter 2).

It has been widely used as a marker

for the activation of protein kinase C in fibroblasts by phorbol esters
(Bishop et a l .. 1985; Blackshear et a l .. 1985; Blackshear et a l .. 1986;
Halsey et a l .. 1986; Rozengurt et al.. 1983; Rodriguez-Pena and
Rozengurt, 1986; Zachary et a l .. 1986; Tsuda et a l .. 1985; Isacke et
a l . . 1986; Sato et a l .. 1985; Coughlin et a l .. 1985; Sagara et a l ..
1986; Wolfman and Macara, 1987; Mahadevan et a l .. 1987), synthetic
diacylglycerols (Blackshear et a l .. 1986; Rozengurt et a l .. 1984; Tsuda
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et a l . . 1985), exogenous phospholipase C (Rozengurt et a l .. 1983), serum
(Rodriguez-Pena and Rozengurt, 1985; Sato et al.. 1985), transformation
(Wolfman and Macara, 1987), and a number of peptides and growth factors
(Blackshear et al.. 1985; Rozengurt et a l .. 1983; Zachary et al .. 1986;
Tsuda et a l .. 1985; Isacke et a l .. 1986; Sato et a l .. 1985; Coughlin et
a l .. 1985; Mahadevan et a l .. 1987).

The protein has also been shown to

be a substrate for protein kinase C in vitro (Wu et a l .. 1982; Walaas et
a l .. 1983a,b; Blackshear et a l .. 1986; Chapters 2 and 3) and to have a
widespread distribution (Blackshear et a l .. 1986; Chapter 3).

The

widespread distribution and prominent phosphorylation of the 87-kDa
protein make it a likely mediator of a major action of protein kinase C.
Tyrosine hydroxylase is the rate-limiting enzyme in the
biosynthesis of catecholamines (Nagatsu et a l .. 1964a).

Several lines

of evidence have suggested that cAMP-dependent phosphorylation may be
one means of activation of tyrosine hydroxylase (see Chapter 4).

In

this dissertation, protein kinase C was also found to phosphorylate and
activate tyrosine hydroxylase (Chapter 4).
Other in vitro and in vivo substrates for protein kinase C include
the EGF receptor (Cochet et a l .. 1984), the interleukin-2 (IL-2)
receptor (Shackelford and Trowbridge, 1984), the transferrin receptor
err

(Davis et a l .. 1986), pp60

(Tamura et a l .. 1984; Gould et a l .. 1985;

Purchio et a l .. 1985, 1986; Gentry et a l .. 1986), p36/p35 (Summers and
Creutz, 1985; Gould et a l .. 1986; Khanna et a l .. 1986; Michener et a l ..
1986), the 47 kDa protein (Castagna et a l .. 1982; Imaoka et a l .. 1983;
Kaibuchi et a l .. 1983; Sano et al.. 1983; Yamanishi et a l .. 1983),
myosin light chain (MLC) (Castagna et a l .. 1982; Endo et a l .. 1982; Naka
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et a l .. 1983; Yamanishi et a l .. 1983; Nishikawa et a l .. 1984), vinculin
(Werth et a l .. 1983, 1984), glycogen synthase (Roach and Goldman, 1983;
Ahmad et a l .. 1984; Ciudad et a l .. 1984; Imazu et a l .. 1984; Arino and
Guinovart, 1986; Blackmore et a l .. 1986), actin-binding protein
(filamin) Carroll et a l .. 1982; Kawamoto and Hidaka, 1984), the glucose
transporter (Witters et a l .. 1985), class I HLA antigens (Feuerstein et
a l .. 1985; Rouis et a l .. 1986; Shackelford and Trowbridge, 1986), and
the 31.5 kDa component of NADPH oxidase (Papini et a l .. 1985).
In most cases, the physiological consequences of phosphorylation
of exact site(s) by protein kinase C remain to be elucidated.

In view

of the difficulties in evaluating whether a protein is a true substrate
for protein kinase C, Woodgett et a l . (1987) have proposed the following
criteria, based on those originally suggested by Krebs for substrates of
cAMP-dependent protein kinase (see Krebs and Beavo, 1979).

(A) The

specific site(s) phosphorylated by protein kinase C in vitro must be
identified, and (B) the protein should be shown to be rapidly
phosphorylated at the same site(s) identified in (A) in vi v o , in
response to agonists of protein kinase C.

Additional corroborative data

are useful, e.g. time course consistent with that of the agonist, loss
of phosphorylation with "down-regulation" of protein kinase C, at least
a fraction of the protein of interest being associated with the
cytoplasmic face of the membrane, and, if possible, the correlation of
an activity change upon phosphorylation in vitro and in vivo.
One protein which thus far meets these criteria is the EGF
receptor.

In many mitogenically responsive cell types, phorbol ester

reduces EGF binding (Lee and Weinstein, 1978; Brown et a l .. 1979; Shoyab
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et a l .. 1979), EGF-induced tyrosine phosphorylation of the receptor, and
the receptor tyrosine kinase activity towards exogenous substrates
(Friedman et a l .. 1984; Cochet et al .. 1984; Decker, 1984; Downward et
a l . . 1985), and can induce transient, reversible internalization of the
receptor (Beguinot et a l .. 1985).

The site of phosphorylation has been

identified as threonine 654 (Hunter et a l .. 1984; Davis and Czech,
1985).

That phosphorylation of threonine 654 is responsible for the

documented effects of tumor promotors on the EGF receptor was recently
confirmed by the generation of mutant receptor molecules in which
threonine 654 was replaced with a non-phosphorylatable alanine residue.
Cells transfected with this mutant DNA no longer lost their high
affinity EGF-binding component upon treatment with tumor promotor, nor
were the receptors internalized in response to the tumor promotor (Lin
et a l .. 1986).
unaffected.

EGF-induced internalization of the mutant receptor was

The effects of phorbol ester on EGF affinity and

phosphorylation of the receptor were mimicked by synthetic
diacylglycerols (McCaffrey et al.. 1984; Davis et a l .. 1985; SinnettSmith and Rozengurt, 1985), PDGF and bombesin (Brown et a l .. 1984).

OBJECTIVES OF THE DISSERTATION

The studies described in this dissertation were undertaken to
analyze the role of protein kinase C in the nervous system.
different approaches were employed.

Three

First, a major endogenous substrate

for protein kinase C in brain, the 87-kDa protein, was identified,
purified and characterized with respect to its physicochemical
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properties and distribution (Chapters 2 and 3).

Second, the effect of

phosphorylation by protein kinase C was examined with a nervous system
protein of known function, namely tyrosine hydroxylase (Chapter 4).
Third, the regulation of protein kinase C activity by calcium-binding
proteins was examined (Chapter 5).
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Chapter 2.

PURIFICATION AND PHYSICOCHEMICAL CHARACTERIZATION OF
THE 87-kDa PROTEIN

The 87-kDa protein is a major substrate for protein kinase C in
vivo and in vitro, and thus fulfills the criteria of a true substrate
for protein kinase C as outlined by Woodgett et al. (1987) (see Chapter

1 .).
Phosphorylation of the 87-kDa protein has been shown to occur in
vivo in response to biological manipulations which initiate PI turnover.
In the nervous system, where the protein was first described as a
component of rat brain synaptosomes (Wu et a l .. 1982), phosphorylation
of the 87-kDa protein was found to be increased in intact rat brain
synaptosomes by depolarization-induced calcium influx (Wu et a l . . 1982;
Wang et a l . . 1985), and in adrenal chromaffin cells (Haycock et a l ..
1987)

and rat brain slices by acetylcholine (Mobley, 1986).

In

fibroblasts, in experiments with proteins which are most likely to be
identical to the 87-kDa protein (see Chapter 3), phosphorylation was
found to be increased in response to serum (Rodriguez-Pena and
Rozengurt, 1985; Sato et a l .. 1985), transformation (Wolfman and Macara,
1987), and a number of peptides and growth factors (Blackshear et a l ..
1985; Rozengurt et a l .. 1983; Zachary et a l .. 1986; Tsuda et al.. 1985;
Isacke et a l .. 1986; Sato et a l .. 1985; Coughlin et a l .. 1985; Mahadevan
et a l .. 1987); and in lymphocytes in response to treatment with
concanavalin A and calcium (Denis et a l .. 1986).

32
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The 87-kDa protein has also been shown to be phosphorylated in
vivo in response to treatment with tumor promoting phorbol esters or
permeant diacylglycerols.

Thus, in the nervous system, phosphorylation

of the 87-kDa protein was found to be increased by phorbol esters or
permeant diacylglycerols in intact rat brain synaptosomes (Wang et al..
1985; Nichols et al.. 1987), in adrenal chromaffin cells (Haycock et
al . . 1987), in astrocytes (Mobley and Harrison, 1987), and in rat
superior cervical ganglion (A. Cahill and R. Perlman, personal
communication).

Increased phosphorylation of the 87-kDa protein was

also shown to correlate with increased calcium-dependent, evoked
neurotransmitter release in response to phorbol ester treatment of rat
brain synaptosomes (Nichols et a l .. 1987).

In fibroblasts,

phosphorylation of the 87-kDa protein was found to be increased by
phorbol esters (Bishop et a l .. 1985; Blackshear et al.. 1985; Blackshear
et al.. 1986; Halsey et a l .. 1986; Rozengurt et al.. 1983; RodriquezPena and Rozengurt, 1986; Zachary et al .. 1986; Tsuda et a l .. 1985;
Isacke et a l .. 1986; Sato et a l .. 1985; Coughlin et al. . 1985; Sagara et
a l .. 1986; Wolfman and Macara, 1987; Mahadevan et al. . 1987), synthetic
diacylglycerols (Blackshear et al.. 1985; Rozengurt et al. . 1984; Tsuda
et a l .. 1985), and exogenous phospholipase C (Rozengurt et a l .. 1983).
In vitro, the 87-kDa protein was found to be phosphorylated by
protein kinase C in crude preparations from brain (Wu et a l .. 1982;
Walaas et a l .. 1983a,b) and other tissues (Chaper 3, Blackshear et al..
1986).

Phosphorylation of the 87-kDa protein by protein kinase C in

vitro has been observed in nerve growth cone preparations (Katz et a l ..
1985), and in response to activation of protein kinase C by a protein
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modulator (Kligman and Patel, 1986).

In addition, phosphopeptide maps

generated from the phosphorylation of the 87-kDa protein in intact cells
have been found to be identical to those obtained in vitro following
phosphorylation of the protein by protein kinase C (Wu et a l .. 1982;
Blackshear et al.. 1985; Blackshear et a l .. 1986; Rodriquez-Pena and
Rozengurt, 1986; Mahadevan et a l .. 1987; Haycock et a l .. 1987; Wang et
al . . 1988).
There is little information concerning the biochemical events
mediating the proposed connection between protein kinase C activation
and cellular responses.

It is important, therefore, to characterize the

physiological substrates for protein kinase C.

The prominent

phosphorylation of the 87-kDa protein in response to activators of
protein kinase C makes it a likely mediator for some major action(s) of
protein kinase C.

The purification and characterization of the 87-kDa

protein described in this chapter was undertaken as a step toward
identifying the role of this protein in the actions of protein kinase C.

MATERIALS AND METHODS

Materials.

Fresh rat forebrain was dissected from a stunned and

decapitated male Sprague-Dawley rat.
on ice from a local slaughterhouse.
from Dr. Angus Nairn.

Fresh calf brains were delivered
Rabbit brain calmodulin was a gift

Antifoam A, ATP, bovine serum albumin (BSA),

C a C ^ , bovine erythrocyte carbonic anhydrase, Coomassie Brilliant Blue
R-250, bovine heart cytochrome c, dimethylsulfoxide (DMSO),
dithioerythritol (DTE), 1,2 diolein, EGTA, HI histone, molecular weight
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protein standards for polyacrylamide gel electrophoresis (PAGE), sodium
dodecyl sulfate (NaDodSO^), bovine brain L-a-phosphatidyl-l-serine, and
Tris were from Sigma.

Ethylene glycol, formic acid, glycerol, KP^, Mg

acetate, NaCl, NaN^, and sucrose were from Fisher.

DEAE-Sephacel, fast

protein liquid chromatography (FPLC) system and ProRPC 5/10 column, gel
filtration calibration kit for high molecular weight proteins, PhenylSepharose, and Sephacryl S-400 Superfine were from Pharmacia.
Other reagents were purchased from the following sources: DE-52
DEAE-cellulose (Whatman); Bio-Gel HTP hydroxylapatite and Affi-Gel Blue
(blue agarose) (Bio-Rad); EDTA and 2-mercaptoethanol (Baker); Ultrapure
(NH^^SO^ (Bethesda Research Laboratories);

32
125
[7 - P]ATP and
I-labeled

protein A (New England Nuclear); antipain, chymostatin, leupeptin, and
pepstatin (Chemicon, El Segundo, CA); Trasylol (FBA Pharmaceuticals, New
York); phenylmethylsulfonyl fluoride (PMSF) and thermolysin (CalbiochemBehring); Staphylococcus aureus V 8 protease (Miles); isopropyl alcohol
(American Burdick & Jackson, Muskegon, MI); trifluoroacetic acid (TFA)
(Pierce); 20 x 20 cm cellulose thin-layer chromatography plates
(Eastman); nitrocellulose, pore size 0.2 ^m (Schleicher & Schuell); and
Nonfat dry milk (Carnation).
Measurement of endogenous calcium/phospholipid-dependent protein
phosphorylation.

Fresh rat and bovine forebrain were homogenized at 0-

4°C with 12 strokes of a glass-Teflon homogenizer at 2100 rpm in a 10 x
volume of 10 mM Tris*HCl (pH 7.6), 2 mM EDTA, 14 mM 2-mercaptoethanol,
Trasylol (25 Kallikrein Inhibitor Units (K.I.U.) per ml), and 100 pH
PMSF.

The homogenates were centrifuged in a Ti50 rotor in a Beckman L2

centrifuge at 150,000 x g for 30 min.

The endogenous phosphorylation
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reaction mixture (final volume 100 /il) contained 20 mM Tris*HCl (pH
7.4), 10 mM Mg acetate, 2 mM DTE, 1 mM EGTA, 50 /j1 of supernatant, and,
where indicated, 5 f i g rabbit brain calmodulin, 1.5 mM C a C ^ , and 5 fig
phosphatidylserine.

The mixture was preincubated for 1 min at 30°C.

32
The reaction was initiated by the addition of [7 - P]ATP (final
concentration, 2 /xM; specific activity 50-100 x 10

3

cpm/pmol), carried

out for 1 min, and terminated by the addition of 20 /xl of NaDodSO^ stop
solution (20% (vol/vol) glycerol/10% (wt/vol) 2-mercaptoethanol/0.25 M
Tris*HCl, pH 6.7, containing a trace of bromophenol blue) and heating in
a boiling water bath for 5 min.
Proteins in the samples were electrophoresed on NaDodSO^/8%
polyacrylamide gels by the method of Laemmli (1970).

The gels were

stained, destained, dried, and subjected to autoradiography as described
(Ueda and Greengard, 1977).
Buffers.

All buffers were cold (0-4°C), and contained 14 mM 2-

mercaptoethanol, 0.02% NaN^, and the following protease inhibitors:
25,000 K.I.U. per liter of Trasylol, 100 fiM. PMSF (plus 0.1% isopropyl
alcohol to dissolve the PMSF), 0.001% leupeptin, 0.001% antipain,
0.0002% pepstatin, and 0.0017% chymostatin (plus 0.1% DMSO to dissolve
the pepstatin and chymostatin).

Buffer A: 10 mM Tris*HCl pH 7.6, 2 mM

EDTA, and 0.5 mM EGTA; Buffer B: 10 mM Tris*HCl pH 7.6, and 1 mM EDTA;
Buffer C: Buffer B with 10% ethylene glycol; Buffer D: 25 mM Tris*HCl pH
7.6, 5 mM MgCl^, 0.5 mM EGTA, and 15% ethylene glycol; Buffer E: 20 mM
Tris*HCl pH 7.5, 0.5 mM EDTA, 0.5 mM EGTA, 15% ethylene glycol, 1.5 M
NaCl, and no Trasylol; Buffer F: 20 mM Tris*HCl pH 7.5, 0.5 mM EDTA, 0.5
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mM EGTA, 25% ethylene glycol, no NaCl, and no Trasylol; and Buffer G: 25
mM Tris*HCl pH 7.6, 1 mM EDTA, 300 mM NaCl, and 10% ethylene glycol.
Measurement of Protein Kinase C Activity.

The protein kinase C

activity reaction mixture (final volume, 100 ji1) contained: 20 mM
Tris*HCl pH 7.4, 10 mM Mg acetate, 1 mM EGTA, 2 mM DTE, 0.1% leupeptin,
50 ;ig BSA, 20 jig Histone HI (Sigma III-S), 10 /il of a 1:50 dilution of
protein kinase C, minus or plus 5 jig phosphatidylserine/0.1 jig diolein
and 1.5 mM C a C ^ .
32

The reaction was initiated by the addition of [7 -

P]ATP (final concentration 50 jiM; specific activity 900-2500 cpm/pmol)

and the simultaneous transfer of the tube from 0° to 30°C.

The reaction

was carried out for five minutes and stopped by the addition of 20 jil of
125 mM EDTA/5 mM ATP and the return of the tube to 0°.
from each tube was pipetted onto a 2 cm
phosphocellulose paper.

2

A 60 jil aliquot

x 2 cm piece of P81 Whatman

The papers were washed with running distilled

water for 25 min and dried under a lamp.

The radioactivity on the

papers was counted in a scintillation counter, either in scintillation
fluid, or dry for the Cerenkov counts on the tritium channel (usually
30-40% of the counts obtained with scintillation fluid).
Purification of Protein Kinase C .

Protein kinase C was purified

to homogeneity from bovine forebrain by modification of the procedure of
Kikkawa et a l . (1982) as follows.
out at 0-4°C.

All purification steps were carried

Each centrifugation was carried out in a Sorvall RC-5B

centrifuge, using a GSA rotor.
Step 1. Homogenization.

1 kg of forebrain was homogenized in 4

volumes of Buffer A for 60 sec with a Polytron.

The homogenate was
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centrifuged for 45 min at 27,000 x g (13,000 rpm), and the pH of the
clear red supernatant was adjusted from 6.8 to 7.6 with 1 N NaOH.
Step 2. DE-52 batch adsorption.

The supernatant was diluted 1:1

with 10 mM Tris*HCl pH 7.5 and was stirred for 1 hr with 1 liter DE-52
which had been equilibrated with Buffer A.

The resin was washed on a

Buchner funnel with 2 liters of Buffer A, then was stirred for 1 hr in 1
liter Buffer A plus 150 mM NaCl.
Step 3. (NH^^SO^ precipitation.

The suspension was filtered on a

Buchner funnel followed by a 1-liter wash with Buffer A plus 150 mM
Na C l .

The clear yellow filtrate was taken to 35% saturation with solid

(NH^ ^ S O ^ and stirred for 1 hr.

The sample was centrifuged for 30 min

at 16,000 x g (10,000 rpm), and the supernatant was taken to 60%
saturation with solid (NH^^SO^ and stirred for 1 hr.

After

centrifugation for 30 min at 16,000 x g, the pellet was resuspended in
250 ml Buffer B and dialyzed overnight against 2 x 5.5 liters of Buffer
B.
Step 4. DEAE-Sephacel chromatography.

After a 20 min, 16,000 x g,

centrifugation to remove particulate material, the dialyzed sample was
applied at 90 ml/hr to a DEAE-Sephacel column (2.5 x 25 cm) previously
equilibrated with Buffer B.

After a 125-ml wash with Buffer B, the

kinase was eluted with a 1 liter linear gradient of 0-200 mM NaCl in
Buffer C.

The kinase eluted in a broad peak at about 75 mM NaCl.

Step 5. Bio-Gel HTP chromatography.

The pooled sample from the

DEAE-Sephacel column was applied directly at 90 ml/hr to a Bio-Gel HTP
column (2.5 x 25 cm) previously equilibrated in Buffer C.

After washes

with 125 ml each of Buffer C, Buffer C plus 1 M NaCl, and Buffer C, the
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kinase was eluted with a 1-liter linear gradient of 0-250 mM KP^ in
Buffer C.

The peak of kinase activity eluted at about 165 mM KP^.

Step 6 . Affi-Gel Blue chromatography.

The pooled Bio-Gel HTP

sample was brought to 10 mM M g C ^ and diluted 1:3 with Buffer D.

The

sample was applied to an Affi-Gel Blue column (1.5 x 17 cm) previously
equilibrated in Buffer D.

After a 30-ml wash with Buffer D, the kinase

was eluted with a 400-ml linear gradient of 0-2.5 M NaCl in Buffer D.
The kinase eluted in a broad peak between 1.75 and 1.93 M NaCl.
Step 7. Phenyl-Sepharose chromatography.

The pooled Affi-Gel Blue

sample was applied directly to a Phenyl-Sepharose column (1.5 x 17 cm)
previously equilibrated in Buffer E.

After a 30-ml wash with Buffer E,

the kinase was eluted with a 200-ml linear gradient of Buffer E to
Buffer F, followed by a 100-ml wash with Buffer F.
a sharp peak at about 0.1 M NaCl.

The kinase eluted in

The pooled purified fraction was

quickly divided into aliquots, frozen in liquid nitrogen, and stored in
a liquid nitrogen freezer.

The final specific activity was usually

about 2.8 pmol/min/mg protein, and the yield about 400 f i g pure protein.
Phosphorylation Assay for the 87-kDa Protein.

The 87-kDa protein

phosphorylation reaction mixture (final volume 100 f i 1) contained 20 mM
Tris*HCl pH 7.4, 10 mM Mg acetate, 1.0 mM EGTA, 2 mM DTE, 0.1%
leupeptin, 0.1% antipain, 1.5 mM C a C ^ ,

5 f i g phosphatidylserine/0.2 f i g

diolein, 3 ng of protein kinase C, and an aliquot of sample containing
the 87-kDa protein.
32

The reaction was initiated by the addition of [7 -

.
P]ATP (final concentration 10 f i K ;

specific activity 5x10

and was carried out for 30 min at 30°C.

6

cpm/nmol)

The reaction was terminated by

the addition of 20 /xl of NaDodSO^ stop solution (20% (vol/vol)
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glycerol/10% (wt/vol) NaDodS0^/10% (vol/vol) 2-mercaptoethanol/0.25 M
Tris*HCl, pH 6.7, containing a trace of pyronin y) and heating in a
boiling water bath for 5 min.

NaDodSO^/8% PAGE was performed according

to the method of Laemmli (1970).

Gels were stained with Coomassie

Brilliant Blue R-250 (0.1% in 50% methanol, 10% acetic acid) and
destained in 30% methanol, 10% acetic acid, or were stained with silver
by the procedure of Poehling and Neuhoff (1981), with the silver reagent
of Ohsawa and Ebata (1983).

Gels were dried onto filter paper in vacuo,

and autoradiography was performed at room temperature or at -70°C (with
Du Pont Cronex Lightning Plus intensifying screens) using Kodak XAR-5 xray film.

Bands containing the 87-kDa protein were excised from the

gels, and the radioactivity was quantitated by liquid scintillation
counting.

Gel pieces containing phosphorylated 87-kDa protein were

subjected to one-dimensional phosphopeptide mapping using S . Aureus V 8
protease as described (Huttner and Greengard, 1979), or to twodimensional phosphopeptide mapping as described (Huttner and Greengard,
1979), except that thermolysin (150 pg/ml) was used instead of trypsin.
The phosphorylated amino acid was identified as described (Hemmings et
a l .. 1984b; Nairn and Greengard, 1987).
Preparation of Antiserum against the 87-kDa Protein.

The 87-kDa

protein that was injected for the preparation of antiserum was purified
as described below with the following exceptions.

Proteins were eluted

from the DE-52 batch adsorption in Buffer A plus 0.3 M NaCl; for
precipitation, the (NH^jSO^ saturation used was 35-55%; proteins were
eluted from the DEAE-Sephacel column with a gradient of 0-300 mM NaCl in
Buffer C; proteins in the DEAE-Sephacel pool were subjected to pH 4:6
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extraction before the Bio-Gel HTP step; proteins in the Bio-Gel HTP pool
were precipitated and applied to an Ultrogel AcA34 (LKB) gel filtration
column; proteins in the Ultrogel Aca34 pool were subjected to
chromatography on an FPLC Mono Q column; and the pure 87-kDa protein was
dialyzed against 20 mM NH^HCO^ and lyophilized.

Antiserum against the

87-kDa protein was prepared in a New Zealand female rabbit by
intradermal injection into multiple sites of 75 p g of the purified
protein emulsified in complete Freund's adjuvant.

The rabbit was given

a booster injection with 50 p g of purified 87-kDa protein at 7 weeks
after the first injection, and was bled at weekly intervals thereafter.
The bleedings at 9-12 weeks after the first injection were used for the
studies described in this thesis.

The antiserum was specific in that it

recognized only the 87-kDa protein when proteins in homogenates of
bovine brain, spleen, adrenal, and testis were subjected to twodimensional gel electrophoresis (see Chapter 3.) followed by
immunoblotting.
Immunoblotting of the 87-kDa Protein.

Immediately following

NaDodSO^/ 8% PAGE, proteins were transferred onto nitrocellulose sheets
(pore size 0.2 pm) at 200 mA for 12 hr using the buffer system of Towbin
et a l . (1979).

All immunoblotting steps were performed at room

temperature in blotting buffer (Johnson et a l .. 1984) (20 mM Tris*HCl pH
7.4, 5% (wt/vol) Nonfat dry milk, 0.02% NaN^, and 0.01% Antifoam A) as
follows: 1 hr in buffer, 2 hr in buffer with a 1:200 dilution of 87-kDa
protein antiserum, 3 x 20 min in buffer, 12 hr in buffer with

125

I-

labeled protein A (2000 cpm/10 p i buffer), and 5 x 20 min in buffer.
The sheets were air dried and autoradiography was performed as described
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above.

Bands containing the 87-kDa protein were excised from the

sheets, and the radioactivity was quantitated by counting in a
Micromedic Systems Automatic Gamma Counter.

Quantitative immunoblotting

was performed by including a standard curve of purified 87-kDa protein
(50-250 ng) on each gel.
Protein determinations.

Protein was determined by the method of

Peterson (1977) using BSA as standard.
Amino Acid Analysis.
extensively against 1^0.

Purified 87-kDa protein was dialyzed

Amino acid analysis was performed by Donna

Atherton of The Rockefeller University Protein Sequencing Facility as
follows: 2 and 4 p g of protein were hydrolyzed for 10, 24, and 72 hr
each.

Amino acids were derivatized, separated and identified as

described (Bidlingmeyer et a l .. 1984).

For determination of cysteine,

10 p g of 87-kDa protein was subjected to performic acid oxidation
(Moore, 1963) followed by amino acid analysis.

A blank contained 10 p g

of 87-kDa protein treated with formic acid only, followed by amino acid
analysis.
Determination of Stokes Radius by Gel Filtration.

Gel filtration

was carried out by the method of Whittaker (1963) in a column (2.5 x 90
cm) of Sephacryl S-400 previously equilibrated with Buffer D.

The

column was calibrated with the following standards: bovine thyroid
thyroglobulin (85.0 A), horse spleen ferritin (61 A), bovine liver
catalase (52.2 A), and rabbit muscle aldolase (48.1 A).

Determination

of the Stokes radius of the 87-kDa protein was carried out according to
the method of Laurent and Killander (1964).
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Determination of Sedimentation Coefficient bv Linear Sucrose
Density Gradient Ultracentrifugation.

Ultracentrifugation was carried

out at 45,000 rpm for 21 hr at 4°C in a Beckman L3-50 Ultracentrifuge
using an SW 50.1 rotor.

Samples plus standards (150 p i )

were layered

onto 5-ml linear sucrose gradients (5 to 20%) which were made in 50 mM
Tris*HCl pH 7.6, 0.2 mM EDTA, 50 mM NaCl, and 14 mM 2-mercaptoethanol.
The standard proteins were: BSA (4.3 S), bovine erythrocyte carbonic
anhydrase (2.85 S ) , and bovine heart cytochrome c (1.83 S ) .

After

centrifugation, 0.25 ml fractions were collected from the bottom of the
tubes and analyzed by the phosphorylation assay for the 87-kDa protein
followed by NaDodS0^/13% PAGE and protein staining.

The sedimentation

coefficient was determined by the method of Martin and Ames (1961).
Time Course and Stoichiometry of Phosphorylation of the 87-kDa
Protein.

The phosphorylation assay for the 87-kDa protein was

performed, except that the reaction mixture contained 1.5 p g of purified
32
87-kDa protein, 80 ng of protein kinase C, and 200 pM [7 - P]ATP
(specific activity 0.2x10^ cpm/nmol).

The tubes were preincubated for 1

min at 30°C, and the reaction was stopped after various times from 20
sec to 70 min.

RESULTS

Identification of the 87-kDa Protein in Bovine Forebrain.

The 87-

kDa protein was originally identified as a component of rat brain
synaptosomes (Wu et a l .. 1982).

The protein was also shown to be

present in all regions of the rat brain (Walaas et a l .. 1983a,b).
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this work, bovine forebrain was investigated as a source of starting
material for the large-scale purification of the 87-kDa protein.
When endogenous phosphorylation was studied in a crude supernatant
fraction from rat forebrain, the addition of calcium plus phosphatidylserine greatly stimulated the phosphorylation of a band in the

85-

90,000 range (Fig. 3), previously identified as the 87-kDa protein.
There was no background phosphorylation in the absence of calcium,
calmodulin, or phosphatidylserine.

The addition of calcium alone or

calcium plus calmodulin resulted in a small, variable, degree of
phosphorylation of bands in the M

87,000 range (Fig. 3).

When

endogenous phosphorylation was studied in a crude supernatant fraction
from bovine brain, the addition of calcium plus phosphatidylserine
greatly stimulated the phosphorylation of a band in the

85-90,000

range (Fig. 3), which was identified as the 87-kDa protein.
some background phosphorylation of the

There was

87,000 band in the absence of

calcium, calmodulin, and phosphatidylserine.

The addition of calcium or

calcium plus calmodulin resulted in a decrease in phosphorylation of the
87,000 band (Fig. 3).

The background phosphorylation in the bovine

preparation was most likely due to endogenous protein kinase M.

The

decrease in phosphorylation upon the addition of calcium was most likely
due to inhibition of the kinase by endogenous calcium-binding proteins
(see Chapter 5).

Treatment of rat or bovine supernatant with cAMP or

cGMP did not result in phosphorylation of the 87-kDa protein.
Therefore, the 87-kDa protein was a prominent substrate for endogenous
phosphorylation by protein kinase C in both rat and bovine forebrain
supernatant.
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Figure 3. Autoradiograms showing phosphorylation of the 87-kDa
protein in rat and bovine forebrain supernatant. The endogenous
calcium/phospholipid-dependent protein phosphorylation assay was carried
out. The indicated additions wejj^ present in the following final
concentrations: free calcium (Ca ), 0.5 mM; rabbit brain calmodulin
(CaM), 1 n g / 1 0 0 fj. 1; phosphatidylserine (PS), 5 pg/100 n 1. After
termination of the phosphorylation reaction, samples were subjected to
one-dimensional NaDodSO^/8% PAGE, followed by autoradiography. -»,
position of the 87-kDa protein. Molecular size markers are shown in
kilodaltons.
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Purification of the 87-kDa Protein from Bovine Forebrain.
purification steps were carried out at 0-4°C.

All

Each centrifugation was

carried out in a Sorvall RC-5B centrifuge, using a GSA rotor.
Step 1. Homogenization.

1 kg of forebrain was homogenized in 4

volumes of Buffer A for 60 sec with a Polytron.

The homogenate was

centrifuged for 45 min at 27,000 x g, and the pH of the clear red
supernatant was adjusted from 6.8 to 7.6 with 1 N NaOH.
Step 2. DE-52 batch adsorption.

The supernatant was stirred for 1

hr with 1 liter DE-52 which had been equilibrated with Buffer A.

The

resin was washed on a Buchner funnel with 2 liters of Buffer A, then was
stirred for 1 hr in 1 liter of Buffer A plus 0.5 M NaCl.
Step 3. (NH^^SO^ precipitation.

The suspension was filtered on a

Buchner funnel followed by a 1-liter wash with Buffer A plus 0.5 M NaCl.
The clear yellow filtrate was taken to 30% saturation with solid
( NH^^SO^ and stirred for 1 hr.

The sample was centrifuged for 30 min

at 16,000 x g, and the supernatant was taken to 60% saturation with
solid (NH^^SO^ and stirred for 1 hr.

After centrifugation for 30 min

at 16,000 x g, the pellet was resuspended in 250 ml of Buffer B and
dialyzed overnight against 2 x 5.5 liters of Buffer B.
Step 4. DEAE-Sephacel chromatography.

After a 20 min, 16,000 x g,

centrifugation to remove particulate impurities, the dialyzed sample was
applied at 90 ml/hr to a DEAE-Sephacel column (2.5 x 25 cm) previously
equilibrated with Buffer B.

After a 125-ml wash with Buffer B, the 87-

kDa protein was eluted with a 1-liter linear gradient of 0-500 mM NaCl
in Buffer C.

The 87-kDa protein eluted in a broad peak between 150 and

250 mM NaCl, with the apex between 180 and 200 mM NaCl (Fig. 4).
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Figure 4. Chromatography of step 3 pool on DEAE-Sephacel.
The
flow rate was 90 ml/hr and 5 -ml fractions were collected. The
phosphorylation assay for the 87-kDa protein was carried out with
aliquots (20 p i ) from every fifth fraction.
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Step 5. Bio-Gel HTP chromatography.

The pooled sample (140 ml)

from the DEAE-Sephacel column was applied directly at 120 ml/hr to a
Bio-Gel HTP column (2.5 x 25 cm) previously equilibrated in Buffer C.
After washes with 125 ml each of Buffer C, Buffer C plus 1 M NaCl and 5
mM M g C ^ , and Buffer C, the 87-kDa was eluted with a 1-liter linear
gradient of 0-350 mM KP^ in Buffer C.

The 87-kDa protein eluted in a

sharp peak at 150 mM KP^ (Fig. 5).
Step 6 . Sephacryl S-400 chromatography.

The proteins in the

pooled Bio-Gel HTP sample (80 ml) were precipitated with (NH^^SO^ (65%
saturation) and resuspended in 5 ml of Buffer G.

The sample was applied

to a Sephacryl S-400 column (2.5 x 90 cm) previously equilibrated in
Buffer G, and the 87-kDa protein was eluted with Buffer G.

One major

peak (peak A) of 87-kDa protein was eluted at 300 ml and one smaller
peak (peak B) (about 30% of the total) was eluted at 360 ml (Fig. 6).
Further purification was performed on the major peak.
Step 7. FPLC ProRPC chromatography.

The pooled sample (40 ml)

from the Sephacryl S-400 column was dialyzed against 2 x 6

liters of 10

mM NH^HCO^ plus protease inhibitors (100 /xM PMSF (plus 0.1% isopropyl
alcohol to dissolve the PMSF), 0.001% leupeptin, 0.001% antipain,
0.0002% pepstatin, and 0.0017% chymostatin (plus 0.1% DMSO to dissolve
the pepstatin and chymostatin); then was dialyzed against another 1 x 6
liters of 10 mM NH^HCO^ plus 0.001% leupeptin and 0.001% antipain.
sample was concentrated to 15 ml under
unit fitted with a PM 10 membrane.
aliquots.

The

in an Amicon Ultrafiltration

This sample was split into 5 x 3 ml

Each aliquot was diluted with 9 ml ^ 0 / 0.1% TFA, filtered

through a Millex-GV 0.22 /xm filter unit (Millipore), and applied at 18
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Figure 5. Chromatography of step 4 pool on Bio-Gel HTP. The flow
rate was 90 ml/hr and 5-ml fractions were collected. The phosphoryla
tion assay for the 87-kDa protein was carried out with aliquots (20 p i )
from every fifth fraction.
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Figure 6 . Chromatography of step 5 pool on Sephacryl S-400. The
flow rate was about 30 ml/hr and 3 -ml fractions were collected. The
phosphorylation assay for the 87-kDa protein was carried out with
aliquots (20 pi) from every fifth fraction. The arrows denote the
positions of elution of: 1 , blue dextran (void volume); 2 , bovine
thyroid thyroglobulin (85 A); 3, horse spleen ferritin (61 &)• 4, bovine
liver catalase (52.2 S ) ; and 5, rabbit muscle aldolase (48.1 A).
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ml/hr to an FPLC ProRPC 5/10 column previously equilibrated in ^ 0 / 0.1%
TFA.

After the column was washed with 12 ml U ^ O / 0.1% TFA, the 87-kDa

protein was eluted at 12 ml/hr with a 40-ml linear gradient of 0-50%
isopropyl alcohol/ 0.1% TFA.

The pH of each fraction was adjusted to

=8 , with an appropriate volume of 1.87 M Tris*HCl pH 8.9, as it was
collected.

The 87-kDa protein eluted as a pure protein in a sharp peak

at about 23% isopropyl alcohol/ 0.1% TFA (Fig. 7).

The fractions

containing the purified 87-kDa protein were pooled, the volume was
reduced in a Speed Vac Concentrator (Savant), the sample was dialyzed
extensively against a buffer of 20 mM Tris*HCl pH 7.6, 14 mM 2mercaptoethanol, and protease inhibitors (100 pM PMSF (plus 0.1%
isopropyl alcohol to dissolve the PMSF), 0.001% leupeptin, 0.001%
antipain, 0.0002% pepstatin, and 0.0017% chymostatin (plus 0.1% DMSO to
dissolve the pepstatin and chymostatin), and the final sample was stored
at 0-4°C.

The purified sample was stable at 0-4°C, whereas it was

partially degraded after any freeze/thaw procedure tested.
The purification procedure for the 87-kDa protein is summarized in
Table 1.

The protein was purified 500-fold from the crude supernatant.

Figure 8 shows the protein staining pattern of samples from each step of
the purification procedure.

Figure 9 shows the purified 87-kDa protein

after Coomassie Blue staining (lane 1) and silver staining (lane 2), and
an autoradiogram of the protein after phosphorylation by protein kinase
C (lane 3).

In each case there was a single band which electrophoresed

with an M^ value of 90,000 on these NaDodSO^/8% polyacrylamide gels.
When the purified phosphorylated 87-kDa protein was subjected to one
dimensional peptide mapping using S . Aureus V 8 protease, phosphopeptides
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Figure 7. Chromatography of step 6 pool on FPLC ProRPC.
The flow
rate was 12 ml/hr and 1-ml fractions were collected. The phosphoryla
tion assay for the 87-kDa protein was carried out with aliquots (40 f i l )
from every fraction.
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Table 1.

Purification of the 87k protein from 1 kg of bovine brain

Purification step

Volume

Protein

ml

mg

87k protein

*

Purity

mg

%

Purification

Yield

-fold

%

1. 27,000xg supernatant

4000

20400

35

0.2

1

100

2. DE-52

2250

7200

10

0.15

1

29

3. (NH^^SO^ precipitation

250

3500

6.3

0.2

1

18

4. DEAE-Sephacel

140

800

5.0

0.6

3

14

5. Bio-Gel HTP

80

33

1.6

5.0

25

4.6

6 . Sephacryl S-400

40

8

0.4

5.0

25

1.1

0.3

0.3

500

0.9

7. FPLC+ , ProRPC 5/10

7.5

Determined by quantitative immunoblotting
FPLC = fast protein liquid chromatography

100

54

1
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'Origin
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Figure 8 . NaDodS0,/8% polyacrylamide gel stained with Coomassie
Brilliant Blue showing the protein staining pattern at each step of the
purification.
Protein values were determined by the method of Bradford
(1976) for pools 1-6 and by the method of Peterson (1977) for pool 7.
Pools: 1, 27,000 x g supernatant (16.2 f i g ) ; 2, DE-52 batch adsorption
(10.9 f i g ) ; 3, (NH ).S0, precipitation (5.3 f i g ) ; 4, DEAE-Sephacel pool
(72.4 f i g ) ; 5, Bio-Gel HTP pool (69.3 f i g ) ; 6 , Sephacryl S-400 peak A pool
(12.5 f i g ) ; 7, FPLC ProRPC pool (4 f i g ) . Molecular size markers are shown
in kilodaltons.
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Figure 9. NaDodS0^/8% polyacrylamide gel stained with Coomassie
Brilliant Blue (lane 1) showing the purified 87-kDa protein (4 f i g ) , and
an autoradiogram (lane 3) showing phosphorylation of the same sample by
protein kinase C. The phosphorylation assay for the 87-kDa protein was
performed, except that the reaction mixture contained 85 mM Tris*HCl and
4 ng protein kinase C, and the reaction was carried out for 2 min.
Another NaDodSO^/ 8% polyacrylamide gel stained with silver (lane 2)
showing the purified 87-kDa protein (1 f i g ) . Molecular size markers are
shown in kilodaltons.
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of

13,000 and 9,000 were generated (Fig. 10A).

When the

phosphorylated protein was subjected to two-dimensional phosphopeptide
mapping using thermolysin, two phosphopeptides were generated, one
acidic and one basic; the acidic peptide was about twice as radioactive
as the basic (Fig. 10B).

Interestingly, two-dimensional phosphopeptide

mapping of either of the

13,000 or 9,000 one-dimensional digest

peptides yielded the same pattern as two-dimensional phosphopeptide
mapping of the whole protein.

The phosphorylated amino acid was

identified as serine (Fig. 10C).

The same one- and two-dimensional

phosphopeptide maps and phosphorylated amino acid were found upon
digestion of the

87,000 band from the rat or bovine crude supernatant

(Wu et a l .. 1982; Chapters 3 and 5), indicating that the purified 87-kDa
protein was identical to the protein whose phosphorylation was
stimulated by calcium plus phosphatidylserine in the crude supernatant.
The 87-kDa protein was also found to have a membrane-bound
fraction (see Chapter 3).

Upon extraction from the particulate fraction

with a nonionic detergent such as 1% Triton X-100, the extracted 87-kDa
protein behaved similarly to the soluble protein on DE-52 and Bio-Gel
HTP chromatography.
Amino Acid Analysis.
protein is shown in Table 2.

The amino acid composition of the 87-kDa
The composition was remarkable for its

very high content of alanine (28.6 mol%), and its high content of
glutamate/glutamine (18.1 mol%).

The protein was also found to be rich

in glycine (12.6 mol%) and proline (11.3 mol%).

The partial specific

volume calculated from the amino acid composition was 0.702 ml/g.
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Figure 10. Phosphopeptides from purified 87-kDa protein
phosphorylated by protein kinase C.
(A) Autoradiogram showing
phosphopeptide map after limited proteolysis with S . aureus V 8 protease.
Phosphorylated 87-kDa protein, located by autoradiography, was excised
and subjected to proteolysis during NaDodSO^/15% PAGE.
13 and 9,
positions of the major and minor phosphorylated fragments derived from
the 87-kDa protein.
(B) Autoradiogram showing phosphopeptide map after
proteolysis with thermolysin. Phosphorylated 87-kDa protein, located by
autoradiography, was excised and subjected to thermolytic digestion
followed by separation in two dimensions on a cellulose plate, first by
electrophoresis in the horizontal direction (positive pole, left;
negative pole, right) and then by ascending chromatography in the
vertical dimension.
(C) Autoradiogram after one-dimensional
phosphoamino acid anaylsis of the phosphorylated 87-kDa protein.
Electrophoresis was carried out on a cellulose plate, 6 cm at pH 1.9,
then 6 cm at pH 3.5.
Ser (P), phosphoserine; Thr (P), phosphothreonine;
Tyr (P), phosphotyrosine: positions of the phosphorylated amino acid
standards by ninhydrin staining.
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Table 2.

Amino acid composition of the 87k protein

Amino acid

4.1

Asx

18.1

Glx
Ser

Mol %

*

9.4

Gly

12.6

His

0.2

Arg
Thr

0.7
*

2.0

Ala

28.6

Pro

11.3

Tyr

0.2

Val*

3.0

Met

0.2

Cys

1.8

lie*

0.0

Leu^

0.6

Phe

1.3

Lys

8.8

Trp

N.D. !

Obtained by extrapolation to zero time
^Value at 72 h
!
'N.D. - not determined
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Molecular Weight Determination.

It was important to determine the

molecular weight of the 87-kDa protein, since the relative molecular
weight on NaDodSO^/PAGE had been reported to vary with acrylamide
concentration (Blackshear et a l .. 1986).

The Stokes radius of peak A on

the Sephacryl S-400 column was calculated to be 85 A (identical value
for 2 determinations)

(Fig. 11), which for a typical globular protein

would correspond to a molecular weight of 669 kDa.

The sedimentation

coefficient of peak A was calculated to be 2.11 ± 0.05 S (n=3) (Fig.
12), which for a typical globular protein would correspond to a
molecular weight of about 16 kDa.

The Stokes radius, sedimentation

coefficient, and partial specific volume were used to calculate the
molecular weight of the 87-kDa protein according to equation 1 of Siegel
and Monty (1966).

A molecular weight of approximately 68 kDa for a

monomer was calculated (Table 3).

The frictional ratio (f/f^) was

calculated by equation 2 of Siegel and Monty (1966) to be 3.2 (Table 3),
which corresponds to an axial ratio of 60 for a prolate ellipsoid
(Schachman, 1959) (Table 3).

All of these data are consistent with a

very asymmetric, highly elongated tertiary structure.
The same properties were examined for peak B.

The Stokes radius

was calculated to be 56 A (identical value for two determinations)

(Fig.

11), which for a typical globular protein would correspond to a
molecular weight of about 320 kDa.

The sedimentation coefficient was

calculated to be 2.01 ± 0.25 S (n - 3) (Fig. 12), which for a typical
globular protein would correspond to a molecular weight of about 14 kDa.
Using these values, a molecular weight of about 43 kDa for a monomer was
calculated.

The frictional ratio was calculated to be 2.45, which
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Figure 11. Determination of the Stokes radius of the Sephacryl S400 peaks of the 87-kDa protein. The column was calibrated with the
following standard proteins: 1 , rabbit muscle aldolase (48.1
; 2,
bovine liver catalase (52.2
3, horse spleen ferritin (61
and 4 ,
bovine thyroid thyroglobulin (85
A,B: the positions of peaks A and
B of 87-kDa protein. The data were treated as described by Siegel and
Monty (1966).
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Summary of physical and chemical properties of the 87k protein

Method of determination

Property
Molecular weight (M^)
*
(M)

Value

NaDodSO^/8% PAGE

87,000-90,000

Stokes radius, sedimentation coefficient

68 kDa

^0

and partial specific volume
00
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Table 3.

Stokes radius (c<)

Gel filtration

Sedimentation coefficient (s.. )
20 ,w

Sucrose density gradient centrifugation

2.11 S

Frictional ratio (f/f^)

Stokes radius, partial specific volume

3.2

and molecular weight
+
Axial ratio 1

Frictional ratio

Amino acid composition

60
High Ala/Glx/Gly/Pro

Partial specific volume (V’)

Amino acid composition

0.702 ml/g

Phosphoamino acid

Phosphorylation by protein kinase C

Ser

Stoichiometry of phosphorylation

Phosphorylation by protein kinase C

2.2

Calculated according to Siegel and Monty (ref. 43)
Value for a prolate ellipsoid (ref. 44)

62

4

-

CO
sS
o

3 ■■

CM

CO

2 -

5

10

1

20

Fraction Number

Figure 12. Determination of the sedimentation coefficient (s~n )
of Sephacryl S-400 peak A 87-kDa protein by sucrose density gradient ,w
ultracentrifugation.
The standard proteins were: bovine serum albumin
(4.3 S ) , bovine erythrocyte carbonic anhydrase (2.85 S ) , and bovine
heart cytochrome c (1.83 S ) . Abscissa, fraction number; ordinate, s„n
(S) ; -*■, position of the 87-kDa protein.
,w
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corresponds to an axial ratio of 33 for a prolate ellipsoid.

These data

are also consistent with an asymmetric, elongated teriary structure.
Stoichiometry of Phosphorylation.

The stoichiometry of

phosphorylation by protein kinase C of the purified 87-kDa protein
(using a value of 68 kDa for the molecular weight) was calculated to be
2.2 mol

32

P incorporated per mol 87-kDa protein after 70 min (Fig. 13).

The addition of another aliquot of kinase at 50 min did not
significantly increase the stoichiometry of phosphorylation at 70 min.
The only amino acid residue phosphorylated by protein kinase C was
serine.

DISCUSSION

The 87-kDa protein, a major, specific substrate for protein kinase
C, was purified to apparent homogeneity from bovine forebrain
supernatant (Table 1, Fig. 9).

Preparation of an apparently homogeneous

protein with only a 500-fold purification indicates that the 87-kDa
protein is highly abundant in brain, comprising 0.2% of total soluble
protein.

The purification procedure included batch adsorption to DE-52,

(NH^ ^ S O ^ precipitation, and chromatography on DEAE-Sephacel, Bio-Gel
HTP, Sephacryl S-400, and an FPLC ProRPC column (Table 1).

The DE-52

and (NH^^SO^ precipitation steps did not result in any overall foldpurification, but were necessary for the efficient use of the DEAESephacel step.

The Sephacryl S-400 step removed certain minor

impurities which were not removed by the FPLC step.

The FPLC ProRPC

column provided a high degree of purification (20-fold), but the
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Figure 13. Time course and stoichiometry of phosphorylation of
purified 87-kDa protein by protein kinase C. The phosphorylation assay
for the 87-kDa protein (0.22 ^M) was carried out for the indicated
periods of time. After termination of the phosphorylation reaction,
samples were subjected to one-dimensional NaDodS0^/8.% PAGE, followed by
autoradiography.
Bands containing the 87-kDa protein were excised from
the gels, and the radioactivity was quantitated by liquid scintilation
counting.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

65

chromatography also exposed the protein to acid conditions (pH 2.5 for
about 3 h) and an organic solvent (up to 23% isopropyl alcohol).
Therefore, each property of the 87-kDa protein was examined with the
sample considered to be most appropriate.

The Stokes radius and

sedimentation coefficient were determined on the Sephacryl S-400 peaks.
At this stage of the preparation the sample had not been exposed to any
denaturing agents (such as heat, acid, detergents, or organic solvents),
so that the values obtained should reflect the native conformation of
the protein.

Phosphorylation by protein kinase C was examined with the

FPLC-purified pool because the purified preparation was free of
endogenous kinase activities.
The hydrodynamic properties of the 87-kDa protein were as follows:
for Sephacryl S-400 peak A, a Stokes radius of 85 A, sedimentation
coefficient of 2.11 S, and frictional ratio of 3.2; for Sephacryl S-400
peak B, a Stokes radius of 56 A, sedimentation coefficient of 2.05 S,
and frictional ratio of 2.45.

The molecular weight calculated from

these properties was about 68 kDa for peak A and about 43 kDa for peak
B, although they electrophoresed with the same apparent molecular weight
on NaDodSO^/ PAGE.
is unclear.

The significance of the difference between the peaks

The sedimentation coefficient, phosphorylation

characteristics, and behavior on other chromatographic systems were
similar for both Sephacryl S-400 peaks.

It is possible that the two

peaks represent subpopulations of the 87-kDa protein that have minor
structural differences.

It is less likely that the major peak

represents a dimer of 87-kDa protein, while the minor peak represents a
monomer.

In this case one would expect a significant difference in the
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sedimentation coefficient and a greater difference in the calculated
molecular weight.

Thus, while the difference between the Sephacryl S-

400 peaks may be of interest, the majority of the 87-kDa protein behaved
as a very asymmetric, highly elongated monomer with a calculated
molecular weight of 68 kDa.
The amino acid composition (Table 2) of the 87-kDa protein was
notable for a very high content of alanine (28.6 mol %), and a high
content of glutamate/glutamine (18.1 mol %), the majority of which is
likely to be glutamate, since the 87-kDa protein has an acidic pi
(multiple forms varying from 4.4 to 4.9) (see Chapter 3).

The protein

was also found to be rich in glycine (12.6 mol %) and proline (11.3 mol
%).

Together, alanine, glutamate/glutamine, glycine, and proline

comprised 70% of the protein.
The purified 87-kDa protein was phosphorylated by protein kinase C
to a stoichiometry of 2.2 mol

32

P per mol 87-kDa protein (calculated

using a molecular weight of 68 kDa), exclusively on serine residues.
Thus there were two or three serine residues phosphorylated by protein
kinase C.
Two other major endogenous substrates for protein kinase C have
been examined in detail.

A platelet protein of

40,000 was first

described by the laboratory of Nishizuka (for reviews see Nishizuka,
1984a,b, 1986), was purified by Imaoka et a l . (1983), and has recently
been identified by Connolly et a l . (1986) as the inositol trisphosphate
5'-phosphomonoesterase which hydrolyzes inositol 1,4,5-trisphosphate.
brain protein, most often referred to as B-50 (Zwiers et a l .. 1980), FI
(Chan et a l .. 1986), or GAP-43 (Skene, 1984), has been purified by
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Zwiers et a l . (1980), Chan et a l . (1986), and Benowitz et a l . (1987),
and has been hypothesized to modulate the activity of phosphatidylinositol 4-phosphate kinase (Van Dongen et al.. 1985).

It will

be of interest to determine whether the 87-kDa protein also has a
function related to the modulation of phosphoinositide metabolism.
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Chapter 3.

SPECIES, TISSUE, AND SUBCELLULAR DISTRIBUTION OF
THE 87-kDa PROTEIN

As described Chapter 2, phosphorylation of the 87-kDa protein has
been shown to occur in intact cells in response to stimulators of PI
turnover and activators of protein kinase C.

The 87-kDa protein was

also shown to be a substrate for protein kinase C in vitro (Wu et al ..
1982; Walaas et al.. 1983a,b; Chapter 2), and was shown to be present in
all regions of the rat brain (Walaas et al.. 1983a,b).

The study of the

species, tissue, and subcellular distribution of the 87-kDa protein
described in this chapter, was undertaken as a step toward identifying
the role of this protein in the actions of protein kinase C.

MATERIALS AND METHODS

Materials and methods were as described in Chapter 2 with the
following exceptions.
Materials. Frozen cerebral cortex from Macaque monkey brain was a
gift from Dr. Tamas Bartfai (Stockholm, Sweden).

Fresh rat tissues were

dissected from stunned and decapitated male Sprague-Dawley rats.

Fresh

bovine tissues were obtained from a local slaughterhouse and were
transported to the laboratory either on ice, in liquid nitrogen, or as a
preparation already homogenized in boiling 1% NaDodSO^.

The heat-stable

68
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protein inhibitor of cAMP-dependent protein kinase (Walsh inhibitor) was
a gift from Dr. Angus Nairn.
Other materials were purchased from the following commercial
sources: benzamidine and Nonidet P-40 (NP-40) (Sigma); calmidazolium
(Boehringer Mannheim); Hepes and S . aureus cells (Pansorbin)
(Calbiochem-Behring); NaDodSO^ (Bio-rad).

All other chemicals used were

reagent grade.
Preparation of Tissue Samples for Phosphorylation.

Monkey

cerebral cortex (stored at -70°C), fresh rat cerebral cortex, and bovine
tissue samples (stored in a liquid nitrogen freezer), were homogenized
at 0-4°C for 60 sec with a Polytron homogenizer in a lOx volume of 20 mM
Hepes pH 7.4, 100 mM NaCl, 2 mM EDTA, 0.5 mM EGTA, Trasylol (50
K.I.U./ml), 100 f M PMSF, 0.001% leupeptin, and 0.0017% chymostatin (plus
0.1% DMSO to dissolve the chymostatin), and filtered through
cheesecloth.

Protein concentration was determined by the method of

Bradford (1976).
Phosphorylation Assay for Endoeenous Substrates of Protein Kinase
C.

The reaction mixture (final volume 100/*1) contained 20 mM Tris*HCl

pH 7.4, 10 mM Mg acetate, 1.0 mM EGTA, 2 mM DTE, 0.72 f i g Walsh
inhibitor, 5 pM calmidazolium, 0.001% leupeptin, and 100 f i g tissue
protein, in the absence or presence of 1.5 mM CaCl^, 5 f i g
phosphatidylserine/0.2 f i g diolein, and 4 ng protein kinase C.

The

32
reaction was initiated by the addition of [7 - P]ATP (final
concentration 2 fiM.; specific activity 22x10^ cpm/nmol), and was carried
out for 60 sec at 30°C.

The reaction was terminated by the addition of

20 f i l of NaDodSO^ stop solution (20% (vol/vol) glycerol/10% (wt/vol)
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NaDodSO^/10% (wt/vol) 2-mercaptoethanol/0.25 M Tris»HCl, pH 6.7,
containing a trace of bromophenol blue) and heating in a boiling water
bath for 5 min.
Proteins (50 f i g ) in the samples were separated by one-dimensional
electrophoresis on NaDodSO^/6-12% mixed exponential-linear gradient
polyacrylamide gels by the method of Kelly and Luttges (1975).

The gels

were stained, destained, dried, and subjected to autoradiography as
described (Ueda and Greengard, 1977).

Radioactivity in phosphorylated

proteins was quantitated by analysis of the gels with an AMBIS Beta
Scanning System (Automated Microbiology Systems, Inc., San Diego, CA).
For two-dimensional gel electrophoresis, proteins (50 f i g ) in the
samples were precipitated with 90% ice-cold acetone, solubilized, and
separated by the method of O'Farrell (1975), using isoelectric focusing
on a pH 3.5-5.8 gradient in the first dimension and NaDodSO^/PAGE in the
second dimension as described above.
Immunoprecipitation of the 87-kda Protein.

Proteins in the

samples were phosphorylated as described above except that the reaction
was terminated by the addition of NaDodSO^ (final concentration 1%).
Samples were then prepared for immunoprecipitation by the addition of an
equal volume of phosphatase inhibitor buffer, pH 7.4 (10% (wt/vol) NP40, 360 mM NaCl, 20 mM NaH2P04> 100 mM NaF, 4 mM EDTA, 4 mM EGTA).
Antiserum was prepared for use in the immunoprecipitation by the
addition of
0.02% NaN^.

50 mM NaF, 2 mM EGTA, 2 mM EDTA, 50 mM benzamidine, and
Solutions for immunoprecipitation: Solution 1: 15 mM HEPES

pH 7.4, 150

mM NaCl, 1 mM EDTA, 0.5% NP-40, and

1% (wt/vol) BSA;

Solution 2:

Solution 1 without BSA; Solution 3: Solution 2 except with
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2.5% NP-40 and 0.5% NaDodSO^.
follows.

Immunoprecipitation was performed as

All steps were carried out at 0-4°C; all centrifugations were

carried out for 3 min at 10,000 x g in a Beckman Microfuge 12.
Preparation of Pansorbin: an aliquot of Pansorbin was pelleted and
resuspended in Solution

3. After 15 min,

the Pansorbin was pelleted and

resuspended in Solution

1. After 15 min,

the Pansorbin was pelleted and

resuspended in Solution

2. The Pansorbin was ready for use after

another cycle of centrifugation and resuspension in Solution 2.
Preclearing of samples: Pansorbin was added to samples (20 y 1
Pansorbin/220 /xl sample).

After 20 min, samples were centrifuged and

the supernatant fractions retained.

Precipitation:

40 y l of 87-kDa

protein antiserum was added to each precleared sample.
y l

Pansorbin was added to each sample.

After 20 min, 80

After 20 min, the samples were

centrifuged, and the pellets were washed twice with Solution 2.

The

pellets were then resuspended in NaDodSO^ stop solution (4% (vol/vol)
glycerol/2% (wt/vol) NaDodSO^/2% (vol/vol) 2-mercaptoethanol/50 mM
Tris*HCl pH 6.7, containing a trace of pyronin y ) , and the samples were
heated in a boiling water bath for 5 min, and then recentrifuged.
Proteins in the final supernatant were subjected to NaDodSO^/PAGE.
Radioactivity in phosphorylated proteins was quantitated by analysis of
the gels with an AMBIS Beta Scanning System.
Immunoblotting of the 87-kDa Protein.

Fresh bovine tissues were

homogenized at the slaughterhouse with an Ultra-Turrax homogenizer in a
lOx volume of boiling 1% NaDodSO^, and heated for another 5 min in a
boiling water bath.

Protein concentration was determined by the method

of Peterson (1977).

Proteins (50 y g )

in the samples were separated by
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one-dimensional electrophoresis on NaDodSO^/6-12% mixed exponentiallinear gradient polyacrylamide gels.

The proteins were

electrophoretically transferred to nitrocellulose sheets at 350 mA for
12 h using the buffer system of Towbin et a l . (1979).

Immunoblotting

125
was performed with [
I]-Protein A as described in Chapter 2.
Radioactivity in labeled proteins was quantitated by analysis of the
blots with the AMBIS Beta Scanning System.
Preparation of Subcellular Fractions.

Subcellular fractions were

prepared from fresh bovine cerebral cortex as described (Whittaker and
Barker, 1972).

The crude synaptosomal fraction (P£) was subdivided into

particulate (P£-P) and cytosol (P2 -S) fractions by hypotonic lysis in
buffer (10 mM Hepes pH 7.4, 2 mM EDTA, 1 mM DTE, and Trasylol (50
K.I.U./ml)) followed by centrifugation at 35,000 x g for 30 min.
Extraction of proteins from the particulate fraction into the same
buffer containing 0.5 M NaCl or 1% NP-40 was performed as described
(Walaas et a l .. 1986).

Each particulate fraction was resuspended in a

volume of buffer equal to that of the final supernatant (S^)•

Proteins

in aliquots (10 /j1) of the fractions were separated by one-dimensional
NaDodSO^/6-12% mixed exponential-linear gradient PAGE and subjected to
immunoblotting as described above.
Immunocvtochemistrv.

The immunocytochemical technique by Ouimet

et a l . (1988) was carried out as follows:

Male Sprague-Dawley rats (150

g) were anesthetized with chloral hydrate (350 mg/kg) and perfused via a
cannula placed through the heart into the aorta with a fixative
containing 2% formaldehyde and 1.25% glutaraldehyde in 0.01 NaPO^ buffer
(pH 7.4).

For light microscopy perfusion with 500 ml of fixative was
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preceded by perfusion with 150 ml of 0.1 M NaPO^ buffer.
omitted for electron microscopic studies.

This step was

Fixative was delivered at a

pressure of 120 mm Hg with a peristaltic pump.

Brains were allowed to

postfix for 1 hr. in situ and were then cut in the coronal plane into
slabs 3 mm thick. The slabs were subsequently cut into sections 100 jtm
thick on a vibratome and collected in phosphate buffered saline (PBS)
containing 0.01 M NaPO^ and 0.15 M NaCl (pH 7.4).

The sections were

then immersed in Na borohydride (1% in PBS) for 30 min, rinsed in PBS (3
x 15 min), and incubated with affinity-purified antibody to the 87-kDa
protein in PBS containing 1% normal horse serum (18 h at room
temperature on a tissue shaker).

Although the antibody to the 87-kDa

protein was already diluted about 1:200 by the process of affinity
purification (method of Olmsted (1981)), the effect of further dilutions
on immunostaining, ranging from 1:10 to 1:10,000, were assessed.

Best

results were obtained with a 1:25 dilution of the purified antibody.
Following incubation with primary antibody, the sections were washed in
PBS (3 x 10 min) and incubated with secondary and tertiary antibody
solutions from a Vector ABC Kit (Vector Laboratories) according to their
instructions.

Sections were incubated with biotinylated horse anti

rabbit IgG (1 h) followed by avidin/biotin/horseradish peroxidase
complex (1 h ) .

PBS washes (3 x 10 min) were used between steps and a

penultimate wash in PBS (3 x 10 min) was followed by a final wash in 0.1
M NaPO^ buffer (pH 7.4) (3 x 10 min).

The sections were then immersed

in 50 ml of 0.1 M NaPO^ buffer containing 25 mg of 3,3 diaminobenzidine
and 10 n l of 30% # 2 ® 2 ^°r ^ m in > anc* washed in NaPO^ buffer (3 x 10
min).

For light microscopy, sections were then mounted on subbed
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slides, coverslipped with Permount, and examined.

For electron

microscopy, sections were osmicated (2% osmium tetroxide in 0.1 M P0^
buffer) (20 min), dehydrated in a graded series of ethanol solutions,
and embedded in EMBED-812 (Electron Microscopic Sciences).

Sections 80

nm thick were cut on an ultratome and examined in a Zeiss JEOL lOOcx
electron microscope without prior staining in lead citrate or uranyl
acetate.

The specificity of the staining protocol was assessed by the

substitution of the following for the primary antibody: diluent without
primary antibody, normal rabbit serum (1 :1000), and serum antibodies
directed against irrelevant antigens.

Potential contamination of the

primary antibody with antibodies against other antigens was avoided by
affinity purification of the primary antibody.

Omission of the second

antibody or of the avidin/biotin/horseradish peroxidase complex produced
a total lack of staining.

RESULTS

Species Distribution of the 87-kDa Protein.

The 87-kDa protein

was observed as a major endogenous substrate for protein kinase C in
homogenates from monkey, rat, and bovine brain (Fig. 14A).

The

of

the 87-kDa protein varied depending on the sample buffer, the gel
system, and the acrylamide concentration used.

In this NaDodSO^/6-12%

mixed exponential-linear gradient polyacrylamide gel, the protein from
monkey and bovine brain had an M

value of 90,000, whereas that from rat

brain had an M^_ value of 83,000 (Fig. 14A).

This difference was

consistent, since in all experiments the phosphorylated 87-kDa proteins
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Figure 14.
(A) Autoradiogram showing phosphorylation of
endogenous substrates for protein kinase C in homogenates of monkey,
rat, and bovine brain. The phosphorylation assay for endogenous
substrates was carried out in the absence (-) or presence (+) of calcium
(500 /iM free), phosphatidylserine (5 fig/100 ;zl)/diolein (0.2 f i g / 1 0 0 f i l ) ,
and protein kinase C (4 ng/100 /zl). After termination of the
phosphorylation reaction by the addition of NaDodSO^ stop solution,
samples (50 fig protein) were subjected to one-dimensional
electrophoresis on NaDodSO^/6-12% mixed exponential-linear gradient
polyacrylamide gels, followed by autoradiography.
(B) Autoradiogram
showing specificity of the immunoprecipitation of the 87-kDa protein
from the mixture of endogenous substrates for protein kinase C in
monkey, rat, and bovine brain.
Phosphorylation was carried out as in
(A) except that the reaction was terminated by the addition of NaDodSO^
(1% final concentration).
Samples were then subjected to im
munoprecipitation with 40 f i l of 87-kDa protein antiserum, followed by
gel electrophoresis as in (A). 90k, position of the 87-kDa protein from
monkey and bovine brain in this gel; 83k, position of the 87-kDa protein
from rat brain in this gel. Molecular size markers are shown in
kilodaltons.
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from rat or mouse brain always had

values 4000-7000 lower than those

from monkey, bovine, or human brain.

Because of the variablility in

of the 87-kDa protein, the small, consistent difference between the
rodent and bovine 87-kDa proteins could be appreciated only when samples
were in the same buffer and were electrophoresed in adjacent lanes on
the same gel.

The 87-kDa antiserum precipitated a single phosphorylated

protein from preparations from monkey, rat and bovine brain (Fig. 14B)
and from human cerebral cortex.

This immunoprecipitation confirmed that

the protein from each species was similar immunologically and that the
rat protein had an
other species.

value 4000-7000 lower than the proteins from the

When subjected to isoelectric focusing, the

phosphorylated proteins from each species were found to be acidic with
multiple (at least three) phosphorylated spots, with pi's ranging from
4 .5-4.8 in the human, 4.4-4.8 in the monkey and bovine, and 4.3-4.6 in
the rat.

When subjected to limited digestion with S . aureus V 8 protease

or limit digestion with thermolysin, the 87-kDa protein from each
species generated the same phosphopeptide maps as the purified 87-kDa
protein (Chapter 2).

These same S . aureus V 8 protease and thermolytic

maps were also generated upon digestion of a similar protein from
Torpedo californica electric organ (R. Huganir, personal communication).
The protein from T. californica electric organ had the same M
the proteins from monkey, bovine, and human brain.

value as

Therefore, the only

detectable differences between the 87-kDa proteins from different
species were that the rodent protein had an M

value 4000-7000 lower,

and was slightly more acidic, than the proteins from the other species
tested.
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Tissue Distribution of 87-kDa Protein.

Endogenous proteins in

homogenates of ten bovine tissues were assayed with exogenous protein
kinase C.

The 87-kDa protein was a prominent substrate in the brain and

lung, and was visible as a substrate in the adrenal, spleen, and testis
(Fig. 15A, Table 4).

When proteins in homogenates from the same tissues

were subjected to immunoblotting, the 87-kDa protein was detected in all
tissues examined (Fig. 15B, Table 4), although the relative
concentration varied among the tissues.

The concentration was highest

in brain, spleen, and lung; moderate (about 30-50% of that in brain) in
testis, pancreas, adrenal, kidney, and liver; and lowest (less than 15%
of that in brain) in heart and skeletal muscle.

Therefore, while the

phosphorylation and immunoblotting results were generally in good
agreement, they showed some differences in the apparent relative amounts
of the 87-kDa protein in the various tissues, e.g. the spleen protein
was less prominent by phosphorylation than by immunoblotting.

Possible

causes for these differences include masking of phosphorylated 87-kDa
protein by other substrates of similar Mr ; differences in ATPase,
phosphoprotein phosphatase, or protein kinase inhibitor activities among
the tissues; and differences in proteolytic activities among the
tissues.

Evidence for the latter possibility was obtained in some

experiments when less fresh bovine tissues were used (prepared more than
five hours after removal from the animal); in these cases a major
proteolytic product of M

47,000 was detected by immunoprecipitation and

immunoblotting.
The 87-kDa proteins from the various bovine tissues were identical
by all criteria examined.

When subjected to one-dimensional
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Figure 15.
(A) Autoradiogram showing phosphorylation of
endogenous substrates for protein kinase C in homogenates of bovine
tissues. The phosphorylation assay for endogenous substrates was
carried out in the presence of calcium (500 /j.K free), phosphatidylserine
(5 Mg/100 Ml)/diolein (0.2 Mg/100 m!), and protein kinase C (4 ng/100
M l ) - After termination of the phosphorylation reaction by the addition
of NaDodSO^ stop solution, samples (50 Mg protein) were subjected to
one-dimensional electrophoresis on NaDodSO^/6-12% mixed exponentiallinear gradient polyacrylamide gels, followed by autoradiography.
(B)
Autoradiogram of immunoblot showing the distribution of the 87-kDa
protein in bovine tissues. Tissue samples were homogenized in a lOx
volume of boiling 1% NaDodSO^, and aliquots (50 Mg protein) were
subjected to one-dimensional electrophoresis on NaDodSO^/6-12% mixed
exponential-linear gradient polyacrylamide gels. The proteins were then
transferred to nitrocellulose sheets and subjected to immunoblotting
w | ^ a 1:200 dilution of the 87-kDa protein antiserum followed by
[
I]-Protein A overlay. Lane numbers represent the following tissues:
1 and 11, cerebral cortex; 2. adrenal; 3, pancreas; 4, lung; 5, liver;
6 , spleen;, 7, heart; 8 , kidney; 9, testis; 10, skeletal muscle.
87k,
position of the 87-kDa protein. Molecular size markers are shown in
kilodaltons.
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Table 4.

Distribution of the 87-kDa protein in bovine tissues

Tissue

Immunoblot

Phosphorylation

Brain

100

100

Lung

64

111

Spleen

83

45

Testis

32

55

Pancreas

37

34

Adrenal

27

35

Kidney

24

30

Liver

20

26

Heart

14

4

7

5

Skeletal Muscle

All values are expressed as % of value in brain.

Samples were

analyzed as described in the legend to Fig. 15.
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electrophoresis on a NaDodSO^/6-12% mixed exponential-linear gradient
gel, each protein was seen as a broad band of M r 90,000 (Fig. 15B).
When subjected to isoelectric focusing, the phosphorylated protein from
each tissue was found to be acidic with multiple spots (at least three)
within the range of pi 4.4-4.9.
adrenal are shown in Fig. 16.

Examples from brain, testis, and
The pi of the major phosphorylated spot

from each tissue varied from experiment to experiment; in the experiment
shown, the major phosphorylated spot was more acidic in the brain than
in testis or adrenal (Fig. 16).

This variability may have been the

result of a post-translational modification, perhaps phosphorylation
itself.

The 87-kDa protein antiserum precipitated a single

phosphorylated protein of similar

from each tissue.

Examples from

brain, testis, and adrenal are shown in Fig. 17A; each protein had an M
value of 80,000 in this NaDodSO^/8% polyacrylamide gel.

Limited

proteolysis with S . aureus V 8 protease of the immunoprecipitated
phosphorylated protein from each tissue generated an identical
phosphopeptide map with major and minor phosphopeptides with M
of 13,000 and 9,000 respectively.

values

Examples from brain, testis, and

adrenal are shown in Fig. 17B.
Analysis of rat tissues with similar techniques gave comparable
results.

Phosphorylation of endogenous substrates with exogenous

protein kinase C showed that the 87-kDa protein was most prominent in
brain, was prominent in lung, spleen, and vas deferens, and was
detectable in testis, pancreas, and liver.

The

value was 80,000 when

proteins were subjected to one-dimensional NaDodSO^/7-12% linear
gradient polyacrylamide gel electrophoresis.

The 87-kDa protein
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Figure 16. Autoradiogram showing heterogeneity of the 87-kDa
protein upon isoelectric focusing.
Phosphorylation was carried out as
described in the legend to Figure 15. After termination of the
phosphorylation reaction, samples (50 f i g protein) were precipitated with
acetone and subjected to two-dimensional electrophoresis using
isoelectric focussing in the first dimension (pH range 3.5-6) followed
by electrophoresis on NaDodSO^/6-12% mixed exponential-linear gradient
polyacrylamide gels in the second dimension. Arrowheads, major
radioactive species in each case.
1 , cerebral cortex; 2 , testis; and 3 ,
adrenal.
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Figure 17.
(A) Autoradiogram showing specificity of the
immunoprecipitation of the 87-kDa protein from various bovine tissues.
Phosphorylation was carried out as described in the legend to Figure 15.
After termination of the phosphorylation reaction by the addition of
NaDodSO^ (1% final concentration), samples were subjected to
immunoprecipitation with 40 f i l of the 87-kDa protein antiserum, followed
by NaDodS0^/8% PAGE. 87k, the 87-kDa protein. Molecular size markers
are shown m kilodaltons. (B) Autoradiogram showing phosphopeptide maps
after limited proteolysis with S . aureus V 8 protease, of immunoprecipitated phosphorylated 87-kDa protein from various bovine
tissues.
Immunoprecipitation was carried out as in (A). Phosphorylated
87-kDa protein, located by autoradiography, was excised and subjected to
limited proteolysis during NaDodSO^/15% PAGE.
13k and 9k, positions of
the major and minor phosphorylated fragments derived from the 87-kDa
protein. Molecular size markers are shown in kilodaltons.
1, cerebral
cortex; 2, testis; and 3, adrenal.
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antiserum precipitated a single M
tissue.

80,000 phosphoprotein from each

When subjected to isoelectric focussing, the phosphoprotein

from each rat tissue generated multiple acidic spots (within the pH
range of 4.0-4.7), and when subjected to limited proteolysis with S .
aureus V 8 protease, generated the same phosphopeptide map as the bovine
protein.

The 87-kDa protein has also been identified by similar

techniques in bovine vascular endothelial cells (Mackie et a l .. 1985).
Therefore, within a given species the 87-kDa protein from each tissue
was identical, although the concentration varied among the tissues, and
the protein from rat tissues was of lower

than the protein from

bovine tissues.
Subcellular Distribution of the 87-kDa Protein.

The 87-kDa

protein from bovine cerebral cortex was found to be distributed as
follows: crude nuclear fraction (P^), 20%; crude synaptosomal membrane
(P2 ’P). 40%; crude synaptosomal cytosol (P^-S), 10%; crude microsomal
fraction (P^), 5%; and cytosol (S^), 25% (Fig. 18A).

This distribution

is similar to that of Synapsin I, a synaptic vesicle-associated protein,
except that there is no Synapsin I in the cytosol (S^) (Huttner et al..
1983).

The 87-kDa protein was not extracted from the crude synaptosomal

membrane (P2-P) by 0.5 M NaCl (Fig. 18B), but was almost completely
extracted by nonionic detergents such as 1% NP-40 (Fig. 18B).

In

contrast, Synapsin I, a peripheral membrane protein, behaved in an
opposite manner, being extracted by 0.5 M NaCl but not by nonionic
detergents (Huttner et a l .. 1983).

In fractionation of a non-neuronal

tissue (testis), the 87-kDa protein partitioned roughly equally between
the particulate and soluble fractions; again, the particulate protein
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Figure 18.
(A) Autoradiogram of immunoblot showing the
distribution of the 87-kDa protein in subcellular fractions from bovine
cerebral cortex.
Proteins in aliquots (10 f i l ) from the fractions were
subjected to one-dimensional electrophoresis and immunoblotting as
described in the legend to Figure 15. Radioactivity in labeled proteins
was quantitated by analysis of the blots with the AMBIS Beta Scanning
System. P^, crude nuclear fraction; P^, crude synaptosomal fraction;
?2 -P and 1*2 '^’ Part^culate an(i soluble fractions, respectively, after
lysis of P^ followed by centrifugation at 35,000xg for 30 min; P.,, crude
microsomal fraction; S^, cytosol.
% of total, cpm in each fraction xlOO
divided by the sum of cpm in all fractions shown.
(B) Autoradiogram of
immunoblot showing extraction of the 87-kDa protein from membrane by
nonionic detergent but not by salt. Fractions were prepared by
resuspension of the P£ -P fraction in buffer containing 0.5 M NaCl or 1%
Nonidet P-40 (NP-40), incubation at 30°C for one hour, and centrifuga
tion at 200,000 x g at 4°C for 30 min. Proteins in aliquots (10 ( i l )
from the fractions were subjected to electrophoresis and immunoblotting
as in (A). NaCl-P and NaCl-S, particulate and soluble fractions,
respectively, after resuspension of P2 -P in buffer containing 0.5 M NaCl
followed by centrifugation.
NP-40-P and NP-40-S, particulate and
soluble fractions, respectively, after resuspension of
buffer
containing 1% NP-40 followed by centrifugation.
% of
cPm
each
fraction xlOO divided by cpm in
Posit:ion of the 87-kDa
protein.
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was not extracted by 0.5 M NaCl but was extracted by 1% NP-40.

Further

evidence for the presence of the 87-kDa protein in the membrane was
obtained by phase separation in Triton X-114 (Bordier, 1981) using rat
cerebellum; the 87-kDa protein partitioned between the detergent and
water phases, whereas Synapsin I was found in the water phase.
Therefore, the 87-kDa protein behaved both as a cytosolic protein and as
an integral membrane protein.
Additional evidence for a membrane-bound fraction of the 87-kDa
protein has recently been obtained by immunocytochemistry.

Light

microscopy results indicated that the protein was present in all regions
of the brain, but was particularly enriched in hypothalamus and
cingulate cortex (Ouimet et a l .. 1988).

Electron microscopy was used to

examine the hypothalamus, the cingulate cortex, and the CA1 region of
the hippocampal complex.

Results were similar in all three areas.

For

example, results within hypothalamus showed staining in glial sheaths
(cell type not yet identified), in small dendrites and spines, and in
axons and nerve terminals (Ouimet et a l .. 1988).

The staining in

dendrites was found throughout the cytoplasm, possibly in association
with microtubules, and was also found along the inner surface of the
plasma membrane (Fig. 19).

(Tissues other than brain have yet to be

examined, and the exact subcellular localizations of the 87-kDa protein
by immunocytochemistry will be confirmed by further experiments).
One possible explanation for the membrane binding of a fraction of
the 87-kDa protein involves post-translational modification.

In

collaboration with Dr. Alan Aderem, in the murine macrophage, a protein
that was recently identified as the 87-kDa protein was found to be
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Figure 19. Electron micrograph of a segment of rat hypothalamus
showing staining of the 87-kDa protein in small dendrites and glial
sheaths as revealed by immunoperoxidase. 100-jtm-thick frozen coronal
sections were stained with affinity-purified antibody to the rat brain
87-kDa protein.
Peroxidase reaction product, which appears black in the
micrograph, is visible in the cytosol of small dendrites (C), along the
inner surface of the membrane of small dendrites (M), and within glial
sheaths (G). Figure from Ouimet et al. (1988).
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phosphorylated in response to treatment with phorbol ester, and was
found to be myristoylated in response to treatment with bacterial
lipopolysaccharide (LPS) (Aderem et a l .. 1988).

The function of

protein-bound myristic acid is only beginning to be understood (for
recent review see Sefton and

Buss (1987)), but it has been shown to have

a role in targeting proteins to the membrane (Pellman

et a l . . 1985;

Cross et al . . 1984; Kamps et a l .. 1985; Rein et a l .. 1986).

Consistent

with this possibility was the finding in the murine macrophage that the
vast majority (> 90%) of the
the membrane (Fig. 20).

myristoylated 87-kDa protein was found in

Thus it is possible that

the particulate

fraction of the 87-kDa protein is bound to the membrane by
myristoylation.

In these same experiments, the majority (> 75%) of the

phosphorylated 87-kDa protein was found in the cytosol (Fig. 20).

The

relationship of myristoylation and phosphorylation to subcellular
distribution of the 87-kDa protein requires further study.

DISCUSSION

The 87-kDa protein was previously identified as a major endogenous
substrate for protein kinase C in broken cell preparations from rat
brain (Walaas et a l .. 1983a,b) and was found to be phosphorylated in
intact nerve terminals (Wu et a l .. 1982; Wang et al.. 1988).

In this

chapter, the 87-kDa protein was identified in tissues from a number of
species.

Thus the 87-kDa proteins from monkey, rat, and bovine brain,

and from a number of rat and bovine tissues, were found to have similar
properties: each was phosphorylated by protein kinase C and was of
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Figure 20. Autoradiograms showing subcellular distribution of
immunoprecipitated 87-kDa protein after treatment of a murine macrophage
preparation with lipopolysaccharide (LPS) followed by phorbol 12myristate 13-acetate (PMA). Murine resident macrophages were isolated
by peritoneal lavage and incubated with H-myristate and S . abortus eoui
LPS (10 ng/ml) (MA) or with
P. and LPS (Pi) for 90 min.
PMA (10
ng/ml) was then added for an additional 30 min. After 2 hr the cells
were lysed by sonication and the membrane (MEM) and cytosol (CYT)
fractions were separated by centrifugation at 100,000 x g for 30 min.
The 87-kDa protein was immunoprecipitated from the fractions and
electrophoresed on NaDodSO^/6-12% PAGE as described (Aderem et a l ..
1986). The murine macrophoage 87-kDa protein electrophoresed at M
68,000 on these gels. -*•, positions of detectable bands; it is likely
that the bands of M lower than 68,000 represent proteolytic products of
the 87-kDa protein m this preparation. Molecular size markers are
shown in kilodaltons.
Figure from (Aderem et a l .. 1988).
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variable M r depending on the sample buffer, gel system, and acrylamide
concentration used; each was recognized by the 87-kDa protein antiserum;
each was acidic and heterogeneous, with multiple phosphorylated spots of
pi within the range 4.3-4.9; and each generated a characteristic
phosphopeptide map upon limited digestion with V 8 protease, with major
and minor peptides of Mr 13,000 and 9,000, respectively.

The 87-kDa

protein was also identified in mouse and human brain and in T.
c a l ifomica electric organ.

The only detectable differences among the

87-kDa proteins were 1) that the relative concentration varied among the
tissues, such that it was highest in brain, spleen, and lung, moderate
in testis, pancreas, adrenal, kidney, and liver, and lowest in heart and
skeletal muscle; and 2) that the protein from all rodent tissues had an
M

value 4,000-7,000 lower, and was slightly more acidic, than the

protein from tissues in the other species examined.
Similar results were obtained by Blackshear et a l . (1986).
identified an acidic,

They

80,000 substrate for protein kinase C in heat-

stable fractions from a number of rat tissues, which was most prominent
in brain.

This substrate had a lower

value and was slightly more

acidic in rat or mouse brain, fibroblasts, or fat pads, than in bovine
brain or fibroblasts, or than in porcine, human, or rabbit brain.

In

addition, an antiserum to their bovine brain M r 80,000 protein
recognized purified bovine brain 87-kDa protein from our laboratory (P.
J. Blackshear and L. Wen, personal communication).
Of particular interest is the subcellular distribution of the 87kDa protein.

In bovine cerebral cortex, most of the 87-kDa protein was

found in the crude synaptosomal fractions and the cytosol.

When
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subfractionation of the synaptosomal fractions was carried out, about
80% of the synaptosomal 87-kDa protein was found in the synaptosomal
particulate preparation; this fraction was almost quantitatively
extracted with nonionic detergents but not with NaCl.

Further evidence

for the membrane localization of a portion of the protein was obtained
in a Triton X-114 phase separation, in which the 87-kDa protein
partitioned between the detergent and water phases.

In addition, by

immunocytochemistry, a portion of the staining of the 87-kDa protein in
dendrites was found along the inner surface of the plasma membrane.
Therefore, the 87-kDa protein behaves both as an integral membrane
and a soluble protein.

A mechanism for the membrane binding of the 87-

kDa protein has been suggested in murine macrophages by the finding that
the protein can be myristoylated.

Also of interest is the finding that

the majority of the myristoylated protein is membrane-bound, while the
majority of the phosphorylated protein is cytosolic.

It is tempting to

speculate that in carrying out its function(s), the 87-kDa protein may
translocate among subcellular compartments.

Myristoylation of the 87-

kDa protein has also been found in rat neuronal cultures (A. Aderem,
K.A.A. , and N. Rosen, data not shown; Perrone-Bizzozero et al.. 1987),
indicating that myristoylation of the protein is likely to be involved
in its function in nervous tissue.
The species, tissue, and subcellular distribution reported here
for the 87-kDa protein follows very closely the reported distribution of
protein kinase C itself (Kikkawa et a l .. 1982; Minakuchi et a l .. 1981;
Kuo et a l .. 1980; Katoh and Kuo, 1982), although the two proteins are
distinct (Chapter 2; Blackshear et a l .. 1986).

This localization
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pattern, coupled with the phosphorylation of the 87-kDa protein in
response to activators of PI turnover, makes the 87-kDa substrate a
likely mediator for certain functions of protein kinase C.

It will be

of interest to determine whether the distribution of the 87-kDa protein,
within brain and within other tissues, follows closely one of the
isozymes of protein kinase C.

Given the widespread tissue and species

distribution of the protein reported here, its function(s) probably
include cellular activities common to many cells.

Further characteriza

tion of this 87-kDa protein, a major endogenous substrate for protein
kinase C, will undoubtedly provide information about the actions of
protein kinase C at the molecular level.
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Chapter 4.

PHOSPHORYLATION AND ACTIVATION OF TYROSINE HYDROXYLASE BY
PROTEIN KINASE C

Nerve stimulation and neurotransmitters have been demonstrated to
accelerate catecholamine biosynthesis in central and peripheral nervous
tissue, adrenal medulla, and pheochromocytoma cells (Ip et a l .. 1982;
Weiner et a l .. 1970; Murrin and Roth, 1976; Greene and Rein, 1978).
This acceleration is thought to result from an increase in the catalytic
activity of tyrosine hydroxylase (tyrosine 3-monooxygenase, EC
1.14.16.2) (cf. Weiner, 1970), the rate-limiting enzyme in the
biosynthesis of catecholamines (Nagatsu et a l .. 1964a).
Several lines of evidence had suggested that cAMP-dependent
phosphorylation might be one means of activation of tyrosine hydroxylase
in situ (cf. Haycock et a l .. 1982a,b and references therein).

Thus,

analogues of cAMP accelerated catecholamine biosynthesis in intact
tissue preparations (Goldstein et a l .. 1976; Meligeni et al.. 1982;
Chalfie et a l .. 1979; Ikeno et a l .. 1981).

In broken cell preparations,

tyrosine hydroxylase could be activated, in the presence of ATP and
magnesium, by cAMP or cAMP-dependent protein kinase (e.g., see Goldstein
et al.. 1976; Morgenroth et a l .. 1975).

Finally, purified tyrosine

hydroxylase had been shown to be phosphorylated and activated by
purified cAMP-dependent protein kinase (Markey et a l .. 1981; Vulliet et
a l .. 1980; Edelman et a l .. 1981).

92
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Other evidence had suggested a role for calcium as well as cAMP in
the activation of tyrosine hydroxylase in situ (Haycock et a l .. 1982a,b;
El Mestikawy et a l . . 1983).

The work in this chapter was undertaken to

analyze the potential role for protein kinase C in the regulation of
tyrosine hydroxylase activity.

It was found that purified protein

kinase C phosphorylated and activated partially purified tyrosine
hydroxylase, in a manner similar to cAMP-dependent protein kinase.

MATERIALS AND METHODS

Materials and methods were as described in Chapters 2 and 3 with
the following exceptions.
Materials.

The catalytic subunit of cAMP-dependent protein kinase

and calcium/calmodulin-dependent protein kinase I were gifts from Dr.
Angus N a i m .

Calcium/calmodulin-dependent protein kinase II was a gift

from Yvonne Lai and Teresa McGuinness.
Other reagents and enzymes were obtained from the following
commercial sources: catalase (Sigma); DL-6-methyl-5,6 ,7,8 tetrahydropterine (6-MePH^) and dopamine (Calbiochem-Behring); Ltyrosine (Eastman); Ag 50W-X8 cation-exchange resin (200-400 mesh, dry,
hydrogen form), and Bio-Rex 9 anion-exchange resin (200-400 mesh, dry,
chloride form) (Bio-Rad); trypsin and chymotrypsin (Worthington); L3
[3,5- H]tyrosine (New England Nuclear).

All other chemicals used were

reagent grade.
Partially purified tyrosine hydroxylase was prepared in the
laboratory of Dr. Menek Goldstein, and had been partially purified as
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described (Markey et a l .. 1980), from the cytosol of cultured PC 12
pheochromocytoma cells, by two cycles of (NH^^SO^ fractionation (80%
and 25-35% saturation) and Sepharose 4B chromatography.

At this stage

of purification, the M r 62,000/60,000 doublet of tyrosine hydroxylase
constituted approximately 75% of the total protein present (estimated
from Coomassie blue protein stain of a NaDodSO^/8% polyacrylamide gel)
(Fig. 2lA).

The specific activity of the fresh preparation, when

measured at pH 6.0, was 0.12 /xmol of dopa formed per min per mg of
protein.

The protein was stored at -70°C for up to three months before

use.
Measurement of Tyrosine Hvdroxvlase Phosphorylation.
mixture (final volume 100 f i l )

The reaction

contained 20 mM Tris*HCl pH 7.4, 10 mM Mg

acetate, 1.0 mM EGTA, 1.5 mM C a C ^ ,

5 f i g phosphatidylserine/0.1 f i g

diolein, 2 mM DTE, 50 f i g BSA, 0.001% leupeptin, and 18 f i g of tyrosine
hydroxylase, in the absence or presence of 72 ng protein kinase C.

The

32
reaction was initiated by [7 - P]ATP (final concentration, 500 /xM;
specific activity, 175 cpm/pmol) and carried out for 15 min at 30°C.
The reaction was terminated by the addition of 20 f i l NaDodSO^ stop
solution (20% (vol/vol) glycerol/10% (wt/vol) NaDodS0^/10% (vol/vol) 2mercaptoethanol/0.25 M Tris»HCl, pH 6.7, containing a trace of
bromophenol blue) and heating in a boiling water bath for 5 min.
The samples were electrophoresed on NaDodSO^/8% polyacrylamide
gels by the method of Laemmli (1970).

The gels were stained, destained,

dried, and subjected to autoradiography as described (Ueda and
Greengard, 1977).

The phosphorylated M^ 62,000/60,000 tyrosine
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Figure 21.
(A) Coomassie blue protein stain of the partiallypurified tyrosine hydroxylase preparation (9.2 f i g ) . (B) Autoradiogram
showing phosphorylation of tyrosine hydroxylase by protein kinase C.
The tyrosine hydroxylase phosphorylation assay was carried out with the
following modifications: 21.6 f i g of tyrosine hydroxylase and 2.4 ng of
protein kinase C were used, and calcium (0.5 mM free) and phosphatidylserine (5 f i g / 1 0 0 /il)/diolein (0.1 f i g/100 f i l ) were^present as indicated.
The reaction was initiated by the addition of [7^ P]ATP (final
concentration, 10 f i K ; specific activity, 15 x 10 cpm/pmol) and carried
out for 2 min. TH, tyrosine hydroxylase. Molecular size markers are
shown in kilodaltons.
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hydroxylase doublet was located by autoradiography and excised, and the
radioactivity was quantitated by liquid scintillation counting.
Measurement of Tyrosine Hvdroxvlase Activity.

Tyrosine

hydroxylase activity was measured by a two-step assay.

In the first

step (preincubation), the tyrosine hydroxylase phosphorylation reaction
was carried out as described above, except that nonradioactive ATP was
used, and the reaction was terminated by the addition of 10 pi of 250 mM
EDTA.

To initiate the second step (incubation) (Nagatsu et a l ..1964b).

two aliquots (50 pi each) of the stopped phosphorylation mixture were
immediately added to tubes containing the reaction mixture for the
measurement of tyrosine hydroxylase activity.

This reaction mixture

(final volume, 110 pi) contained (final concentrations) 200 mM Na
phosphate buffer (pH 7.0), 0.1 mM 6-MePH^, 100 pM L - [3,5-^H]tyrosine
(specific activity, 1 pCi/4 nmol), 800 units of catalase, and 90 mM NaF.
The reaction was carried out at pH 7.0 rather than pH 6.0, because
tyrosine hydroxylase activity at pH 6.0 in the absence of protein kinase
C was too high to obtain a reliable activation curve.

The reaction was

carried out for 5 min at 37 °C and terminated by the addition of 200 pi
of 0.1 M NaOH.

The stopped reaction mixtures were passed through ion

exchange columns (0.1 x 1.5 cm) consisting of equal volumes of anion
exchange resin (Bio-Rex 9, upper layer) and cation exchange resin (Ag
50W-X8, lower layer).
of water.

The columns were washed with 0.5 ml, then 1.0 ml,

Tritiated water was measured in the flow-through by liquid

scintillation counting.
Additional Methods.

Two-dimensional peptide mapping was performed

as described (Huttner and Greengard, 1979), except that chymotrypsin (50
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H g/m l)

was used in addition to trypsin (75 jig/ml).

Protein

determination was performed by the method of Peterson (1977) with BSA as
standard.

RESULTS

Phosphorylation of Tvrosine Hvdroxvlase.

In the presence of

calcium, protein kinase C phosphorylated tyrosine hydroxylase in a
phosphatidylserine/diolein-dependent manner (Fig. 21B).

The maximum

stoichiometry achieved with this preparation of tyrosine hydroxylase was
about 0.5 mol of

32

P per mol of

62,000/60,000 doublet.

Basal

phosphorylation of tyrosine hydroxylase (in the absence of added protein
kinase C (not shown), or in the presence of added protein kinase C
without activators (Fig. 21B)), constituted less than 20-25% of the
phosphorylation seen in the presence of protein kinase C with activators
(Fig. 21B).

The basal phosphorylation of tyrosine hydroxylase seen in

the absence of added protein kinase C was not affected by the addition
of calcium, phosphatidylserine/diolein, calmodulin, or Walsh inhibitor.
Measurement of Phosphorylation and Activity of Tvrosine
Hvdroxvlase in the Absence and Presence of Protein Kinase C .

The

phosphorylation and activity of tyrosine hydroxylase were measured in
parallel by the two-step assay, in which phosphorylation was carried out
in the first step and tyrosine hydroxylase activity was measured in the
second step.

In the presence of protein kinase C, the phosphorylation

of tyrosine hydroxylase increased with time and reached a plateau after
about 20-30 min (Fig. 22A).

Addition of a second aliquot of protein
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Figure 22. Time course of phosphorylation (A) and activation (B)
of tyrosine hydroxylase by protein kinase C.
(A) The first step of the
two-step assay (the preincubation s t e ^ t o phosphorylate tyrosine
hydroxylase) was carried out with [7 - P]ATP (specific activity, 175
cpm/pmol) at 30°C for the times indicated and was terminated by the
addition of 20 jil of NaDodSO^ stop solution. After gel electrophoresis,
the M 62,000/60,000 tyrosine hydroxylase doublet, located by
autoradiography, was excised, and the radioactivity was quantitated by
liquid scintillation counting.
(B) The first step (preincubation) of
the standard assay was carried out with nonradioactive ATP at 30°C for
the times indicated, followed by the second step (incubation) at 37°C
for 5 min. Each point represents the mean of duplicate samples.
*, In
the presence of protein kinase C; o, in the absence of protein kinase C;
1, addition of a second aliquot of protein kinase C.
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kinase C at 40 min resulted in a further increase in phosphorylation,
indicating that the first plateau was attributable to inactivation of
the kinase.
Tyrosine hydroxylase activity in the presence of protein kinase C
increased along with phosphorylation up to 15 min (Fig. 22B), after
which there was a sharp decline in activity.

Addition of a second

aliquot of protein kinase C at 40 min did not restore activity.

A

decrease in activity with increasing time of phosphorylation has also
been reported in studies with cAMP-dependent phosphorylation of tyrosine
hydroxylase (e.g. see Vrana and Roskoski, 1983), and has been attributed
to an increased susceptibility to denaturation of the phosphorylated
form of the enzyme relative to the dephosphorylated form (Vrana and
Roskoski, 1983).

There was little or no change in tyrosine hydroxylase

activity as a function of time of preincubation in the absence of
protein kinase C (Fig. 22B).

Calcium/calmodulin-dependent protein

kinase I (Nairn and Greengard, 1987) did not phosphorylate or activate
tyrosine hydroxylase, and calcium/calmodulin-dependent protein kinase II
phosphorylated but did not activate tyrosine hydroxylase, probably
because the necessary protein activator was not present (see below).
Effect of Phosphorylation of Tvrosine Hvdroxvlase on Its Affinity
for 6 -MePH^.

The

for 6-MePH^ was determined for tyrosine hydroxylase

in the absence and presence of protein kinase C by the two-step assay
(with the first step carried out for 15 min), except that the
concentration of 6 -MePH. was varied from 0.1 mM to 1.0 mM.
4

The K

m

for

6 -MePH^ was 0.45 mM in the absence of protein kinase C and 0.11 mM in
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the presence of protein kinase C (Fig. 23).
V

There was no change in

max
Effect of Phosphorylation of Tvrosine Hvdroxvlase on Its Affinity

for Tvrosine.

The

for tyrosine was determined for tyrosine

hydroxylase in the absence and presence of protein kinase C by the twostep assay (with the first step carried out for 15 min), except that the
concentration of tyrosine was varied from 10 to 100 pM, and the second
step was carried out for 6 min.
alter the K
apparent V

m

Protein kinase C did not significantly

value for tyrosine, but it did cause a 30% increase in

m&x

(Fig. 24).

This small increase in apparent V

max

probably

resulted from the increased affinity for 6-MePH^ (see above), which was
subsaturating in these assays.
Effect of Phosphorylation of Tvrosine Hvdroxvlase on Its
Suscentibitv to Inhibition by Dooamine.

The

for dopamine inhibition

of tyrosine hydroxylase activity in the absence and presence of protein
kinase C was determined by the two-step assay with the following
exceptions: the first step was carried out for 13 min and the second
step for 6 min; dopamine concentration was varied from 2 to 80 pM; two
concentrations of 6 -MePH^ (0.1 and 1.0 mM) were used; and the second
step was carried out at pH 6.0 rather than 7.0, because tyrosine
hydroxylase activity at pH 7.0 in the absence of protein kinase C was
too low to obtain a reliable inhibition curve.
a Dixon plot.

The

The data was analyzed by

for dopamine in the absence of protein kinase C

was calculated to be 4.2 pM (Fig. 25, upper panel).
presence of protein kinase C was more complex.

The data in the

The data at 1.0 mM 6 -

MePH^ yielded a straight line, but the data at 0.1 mM 6 -MePH^ yielded a
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Figure 23. Lineweaver-Burk plot of tyrosine hydroxylase activity
as a function of MePH^ concentration, in the presence (•) and in the
absence (o) of protein kinase C. Each point represents the mean of
duplicate samples.
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Figure 24. Lineweaver-Burk plot of tyrosine hydroxylase activity
as a function of tyrosine concentration, in the presence (•) and in the
absence (o) of protein kinase C. Each point represents the mean of
duplicate samples.
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Figure 25. Dixon plots of tyrosine hydroxylase activity as a
function of dopamine and 6-MePH, concentrations, in the absence (upper
panel) and presence (lower panel) of protein kinase C. The two-step
assay was carried out at the indicated concentrations of dopamine and 6MePH^ for 6 min.
Each point represents the mean of duplicate samples.
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curve which could be resolved into two components (Fig. 25, lower
panel).

With one component, formed with the data from 25-80 pH dopamine

(Fig. 25, lower panel, extrapolated broken line), a K. for dopamine of
47.5 pH could be calculated.
data from 2-25 p H dopamine, a

With the second component, formed with the
for dopamine of 4.7 p H could be

calculated (Fig. 25, lower panel).

The most likely explanation for

these two components is that they represent phosphorylated (K^ 47.5 pH)
and dephosphorylated (K^ 4.7 pH) pools of tyrosine hydroxylase within
the reaction mixture.

Thus, phosphorylation of tyrosine hydroxylase by

protein kinase C causes an increase in the

for dopamine.

Comparison of Phosphopeptide Maps of Tyrosine Hvdroxvlase
Phosphorylated by Protein Kinase C and by the Catalytic Subunit of cAMPDependent Protein Kinase.

Tyrosine hydroxylase, after phosphorylation

by protein kinase C, the catalytic subunit of cAMP-dependent protein
kinase, or both, was subjected to tryptic/chymotryptic digestion and
subsequent two-dimensional separation on celloluse plates.

The pattern

in each case was identical (Fig. 26), indicating that the two kinases
probably phosphorylated the same site(s) on tyrosine hydroxylase.
Furthermore, analysis of phosphorylated amino acids indicated that only
serine residues were phosphorylated.
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Figure 25. Autoradiogram showing tryptic/chymotryptic
phosphopeptide maps of tyrosine hydroxylase phosphorylated by the
catalytic subunit of cAMP-dependent protein kinase (40 ng) (A); by
protein kinase C (72 ng) (B); and by the catalytic subunit of cAMPdependent protein kinase (40 ng) plus protein kinase C (72 ng) (C).
Both steps of the two-step assay, namely phosphorylation and tyrosine
hydroxylase activity, were carried out before phosphopeptide mapping, so
that the pattern of phosphorylation could be analyzed at a point
equivalent to that at which tyrosine hydroxylase activity had been
measured.
The two-step assay was carried out as described (Materials
and Methods), with the following exceptions: b ^ h steps were carried out
for 10 min; BSA and catalase were omitted; [7 - P]ATP (specific
activity, 175 cpm/pmol) and nonradioactive tyrosine were used; the
second step was terminated by the addition of NaDodSO, stop solution.
After gel electrophoresis, the M 62,000/60,000 tyrosine hydroxylase
doublet, located by autoradiography, was excised and subjected to
tryptic/chymotryptic digestion followed by separation on cellulose
plates, first by electrophoresis in the horizontal direction (negative
pole left, positive pole right), and then by ascending chromatography in
the vertical direction, o, Origin.
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DISCUSSION

The results in this chapter supported and extended the data of
Raese et a l . (1979), which had suggested that protein kinase C might
phosphorylate and activate tyrosine hydroxylase.

We found that

phosphorylation and activation of tyrosine hydroxylase by protein kinase
C was characterized by a decrease in the K for the 6-MePH. cofactor, an
J
m
4
increase in the

for dopamine, no change in the

for tyrosine, and

little or no change in apparent vmax under any of the conditions tested.
Similar effects on the kinetics of tyrosine hydroxylase were found
previously when the enzyme was phosphorylated in vitro by cAMP-dependent
protein kinase (e.g., see Vulliet et a l .. 1980; Ames et a l .. 1978).
Moreover, the cAMP-dependent activation of tyrosine hydroxylase in situ
had also been characterized by a decrease in K for the cofactor with no
J
m
change in Km for tyrosine and no change in V

(e.g., see Goldstein et

a l .. 1976; Meligeni et a l .. 1982).
Studies of the sites of phosphorylation have also been useful in
correlating activation of tyrosine hydroxylase with a variety of
treatments.

In this chapter, the phosphopeptide maps of tyrosine

hydroxylase were found to be identical whether in vitro phosphorylation
was catalyzed by protein kinase C, the catalytic subunit of cAMPdependent protein kinase, or both (Fig. 26).

Thus, the similar kinetic

effects of the two kinases may be attributable to phosphorylation of the
same site(s) on the substrate.

Reports from other laboratories have

confirmed this finding (Vulliet et a l .. 1985; Campbell et a l . . 1986).
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There is general agreement that stimulation with cAMP increases
the phosphorylation of tyrosine hydroxylase at a single site whether
examined in chromaffin cells (Haycock et a l .. 1982a,b) or PC 12 cells
(Tachikawa et a l .. 1986; Griffith et a l .. 1985).

This site matches the

site specificity of phosphorylation by cAMP-dependent protein kinase in
vitro (Vulliet et a l .. 1985; Tachikawa et al.. 1986; Griffith et a l ..
1985).

The site has been identified by peptide sequencing and

comparison to the sequence obtained from the rat cDNA sequence as
serine-40 (Campbell et a l .. 1986).
Activation of protein kinase C in situ, by the addition of phorbol
esters, leads to the phosphorylation and activation of tyrosine
hydroxylase (Pocotte and Holz, 1986; Griffith et a l .. 1985).

Since

muscarinic agonists stimulate PI turnover and increase tyrosine
hydroxylase activity (Horwitz et a l .. 1984), it is possible that protein
kinase C is a mediator of muscarinic action in this case.

The same site

as the site phosphorylated by cAMP-dependent protein kinase, serine-40,
is phosphorylated by stimulation of cells in situ with phorbol esters
(Griffith et a l .. 1985) and by protein kinase C in vitro (Campbell et
a l .. 1986; Griffith et a l .. 1985).

Phosphorylation of serine-40 by

protein kinase C is consistent with a requirement for arginine residues
on the N-terminal side of the phosphorylated residue, as deduced from
studies with other protein substrates and with synthetic peptides
(Turner et a l .. 1985).
There is also evidence for the involvement of calcium/calmodulindependent protein phosphorylation in the in situ activation of tyrosine
hydroxylase (Ames et a l .. 1978; Haycock et a l .. 1982a,b; El Mestikawy et.
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a l .. 1983; Raese et a l .. 1979; Yamauchi and Fujisawa, 1981).

The in

situ calcium-dependent, depolarization-induced activation of tyrosine
hydroxylase is characterized by an increase in V
K

for the cofactor (El Mestikawy et a l .. 1983).

, with no change in
It was reported and

recently confirmed that calcium/calmodulin-dependent protein kinase II
phosphorylates tyrosine hydroxylase in vitro but does not activate it
unless a protein activator is present (Yamauchi and Fujisawa, 1981;
Atkinson et a l . . 1987).
increase in V
a l .. 1987).
results.

max

This phosphorylation is characterized by an

, with no change in K

m

for the cofactor (Atkinson et

Studies with phosphopeptide mapping have confirmed these

Elevation of intracellular calcium leads to the phosphoryla

tion and activation of tyrosine hydroxylase (Nose et a l .. 1985;
Tachikawa et a l .. 1986; Griffith et a l .. 1985); the pattern of
phosphopeptides matches the pattern obtained with calcium/calmodulindependent protein kinase II (Tachikawa et a l .. 1986; Griffith et al..
1985).

The major site of phosphorylation of tyrosine hydroxylase by

calcium/calmodulin-dependent protein kinase II has been identified as
serine-19 (Campbell et a l .. 1986).
In summary (Fig. 28, from Atkinson et al.. 1987), protein kinase C
and cAMP-dependent protein kinase phosphorylate tyrosine hydroxylase on
serine-40 and activate it by increasing the affinity for the cofactor.
Calcium/calmodulin-dependent protein kinase II, in the presence of a
protein activator, phosphorylates tyrosine hydroxylase on serine-19 and
activates it by increasing the v

•

Serine-40 is also phosphorylated

by cGMP-dependent protein kinase (Campbell et al., 1986).

In addition

to these well-defined kinase-residue phosphorylation events of tyrosine
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Figure 27. Regulation of tyrosine hydroxylase activity by protein
kinases.
cAMP-dependent protein kinase and protein kinase C both
phosphorylate serine-40 on tyrosine hydroxylase and activate it by a
mechanism characterized by an increase in affinity for the cofactor with
no change in V
. Calcium might also activate tyrosine hydroxylase by
phosphorylation on serine-19 by calcium/calmodulin-dependent protein
kinase II. This phosphorylation requires the presence of a protein
activator, and is characterized kinetically by an increase in V
, with
no change in affinity for the cofactor.
In addition to the cAM?fX
protein kinase C, and calcium/calmodulin-dependent phosphorylation and
activation of tyrosine hydroxylase, there are also other sites
phosphorylated in vivo for which kinases have not yet been identified.
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hydroxylase, there is a third site, serine 8 , which is found to be
endogenously phosphorylated, and for which there is no known kinase
(Campbell et a l .. 1986); and there is a fourth site, which is
phosphorylated in adrenal chromaffin cells in response to acetylcholine,
and for which there is no known kinase (J. Haycock, personal
communication).

Therefore, additional phosphopeptides of tyrosine

hydroxylase have yet to be well-defined in terms of kinase and
functional consequences (McTigue et al .. 1985; Campbell et a l .. 1986;
Tachikawa et a l .. 1986; Griffith et a l .. 1985).
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Chapter 5.

INHIBITION OF PROTEIN KINASE C BY CALCIUM-BINDING PROTEINS

It has been over 100 years since the presentation of the first
evidence that calcium is important in muscle contraction (Ringer, 1883).
Subsequently, calcium was shown to be involved in numerous physiological
processes, including exocytosis (for review see Hutton, 1986).
The cell maintains its calcium homeostasis with the use of
numerous calcium transporting systems (for review see Carafoli, 1987).
In the cytosol, calcium accomplishes its intracellular messenger
functions by binding to specific calcium-binding proteins, many of which
share common properties.

These proteins are of relatively small M

(10,000-20,000), are negatively charged at neutral pH (are of pi 4-5),
and bind two to four calcium ions with high affinity.

Members of this

group include troponin C, S-100 protein, parvalbumin, and calmodulin.
Troponin C was the first to be discovered (Ebashi and Kodama, 1965;
Ebashi et al.. 1967), is restricted to striated muscle, and is part of
the chain of molecular events that produces muscle contraction.

S-100

protein, discovered as a protein in glial cells (Moore, 1965), exists as
two proteins that are dimers of highly homologous subunits, S-lOOa (a/3)
and S-lOOb (/S/9) (Isobe and Okuyama, 1978; Isobe et al. . 1981).
Parvalbumin, a muscle protein that is particularly abundant in fishes,
amphibia, and reptiles, was the first whose structure was studied in
detail, and with it, Kretsinger and his colleagues (Kretsinger and
Nockolds, 1973; Kretsinger and Nelson, 1977) established a series of

111
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general structural principles for the high-affinity binding of calcium
by these proteins.

It is now clear that calmodulin is the most

versatile of these proteins (for review see Klee and Vanaman, 1982).
Calmodulin was first detected as a protein factor that stimulated the
activity of preparations of brain cyclic nucleotide phosphodiesterase
(Cheung, 1970).

Subsequently, the calcium dependence of phosphodies

terase was shown to be a consequence of calcium binding to calmodulin
(Teo and Wang, 1973).

Since that time, studies of calmodulin and the

enzymes that it activates have led to an appreciation of the general
significance of calcium as a mediator of cellular regulation.

Many of

the effects of calmodulin are achieved through stimulation of protein
phosphorylation (see Chapter 1).
Calmodulin has also been reported to act as an inhibitor.

It was

reported to inhibit the phosphorylation of low molecular weight brain
membrane proteins (Thayer et al.. 1983), the cAMP-dependent protein
kinase-catalyzed activation of phosphorylase kinase (Cox and Edstrom,
1982), and the polyamine-dependent protein kinase phosphorylation of
ornithine decarboxylase (Atmar and Kuehn, 1983).

Calmodulin has also

been suggested to play a role in the guanine nucleotide-mediated
inhibition of rat hippocampal adenylate cyclase (Girardot et a l ..19831).
and to inhibit coupled NaCl transport in membrane vesicles from rabbit
ileal brush border (Fan and Powell, 1983).
In preparations from rat brain synaptosomes, the addition of
exogenous calmodulin was previously found to inhibit the in vitro
phosphorylation of the 87-kDa protein by endogenous protein kinase C (Wu
et a l .. 1982).

The work in this chapter was undertaken to characterize
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this inhibition with purified components, in order to begin to assess
the possible role of calmodulin or other calcium-binding proteins as
endogenous inhibitors of protein kinase C.

MATERIALS AND METHODS

Materials and methods were as described in Chapters 2-4, with the
following exceptions.
Materials.

Rat brain cytosol was depleted of calmodulin as

described for rat brain synaptosomal cytosol (Wu et a l .. 1982).

Human

erythrocyte calmodulin, bovine brain S-100 protein, and rat muscle
parvalbumin were purchased from Calbiochem-Behring.

Rabbit skeletal

muscle troponin C was a gift from P. Leavis (Boston Biomedical Research
Institute).

S-100 protein, parvalbumin, and troponin C were found to be

free of calmodulin contamination by their inability to activate
calcium/calmodulin-dependent protein kinase I (Nairn and Greengard,
1987).
Purification of Protein kinase C and 87kDa.
purified as described in Chapter 2.

The enzyme was

The 87-kDa protein was purified as

decribed in Chapter 2 (Results) with the following exceptions: proteins
were eluted from the DE-52 batch adsorption in Buffer A plus 0.3 M NaCl;
no (NH^^SO^ precipitation step was performed after DE-52 batch
adsorption; proteins were eluted from the DEAE-Sephacel column with a
gradient of 0-350 mM NaCl in Buffer C; proteins in the DEAE-Sephacel
pool were subjected to pH 4:6 extraction before the Bio-Gel HTP step;
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proteins were eluted from the Bio-Gel HTP column with a gradient of 0300 mM KP^ in Buffer C; proteins in the Bio-Gel HTP pool were
precipitated and applied to an Ultrogel AcA34 column; proteins in the
Ultrogel Aca34 pool were subjected to chromatography on Phenyl-Sepharose
as described for protein kinase C (Chapter 2); proteins in the PhenylSepharose pool were rechromatographed on Bio-Gel HTP; and the second
Bio-Gel HTP pool was rechromatographed on a DE-52 column.

The final

protein kinase C and 87-kDa protein electrophoresed as single protein
bands of Mr 87,000 on NaDodS04/8% PAGE (Fig.27).
Measurement of Phosphorylation of the 87-kDa Protein by Protein
Kinase C .

The reaction mixture (final volume 100 /il) contained 20 mM

Tris*HCl (pH 7.4), 10 mM Mg acetate, 2 mM DTE, 0.1% leupeptin, 40-80 ng
of protein kinase C , 0.13 fig of the 87-kDa protein, 1 mM EGTA, and,
where indicated, 5 n g rabbit brain calmodulin, 1.5 mM C a C^,
phosphatidylserine.

and 5 f i g

The mixture was preincubated for 1 min at 30°C.

32
The reaction was initiated by the addition of [7 - P]ATP (final
3
concentration, 2 /iM; specific activity 50-100 x 10

cpm/pmol), carried

out for 1 min, and terminated by the addition of 20 f i l of NaDodSO^ stop
solution (20% glycerol/10% (wt/vol) 2-mercaptoethanol/0.25 M Tris*HCl,
pH 6.7, containing a trace of bromophenol blue) and heating in a boiling
water bath for 5 min.
The boiled samples were electrophoresed on NaDodSO^/8%
polyacrylamide gels by the method of Laemmli (1970).

The gels were

stained, destained, dried, and subjected to autoradiography as described
(Ueda and Greengard, 1977).

Silver staining of the enzyme (Morrissey,

1981) and of the substrate (Poehling and Neuhoff, 1981) was performed as
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Figure 28. Protein stain of the final purified preparations of
protein kinase C and the 87-kDa protein.
The proteins were subjected to
one-dimensional NaDodSO^/8% PAGE and silver-stained.
Protein kinase,
protein kinase C; 87k, the 87-kDa protein. Molecular size markers are
shown in kilodaltons.
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described.

The phosphorylated substrate was located by the

autoradiogram and excised, and the radioactivity was quantitated by
liquid scintilation counting.

All assay conditions were such that

phosphorylation was linear with time, substrate concentration, and
enzyme concentration.

In all cases, a low enough ratio of enzyme to 87-

kDa protein was used so that enzyme autophosphorylation did not
contribute significantly to phosphorylation measured in the M

87,000

region of the gels. Two-dimensional peptide mapping was performed as
described (Huttner and Greengard, 1979), except that thermolysin (150
/ig/ml) was used.

Protein determination was performed by the procedure

of Peterson (1977) with BSA as standard.

RESULTS

Inhibition by Calmodulin of Phosphorylation of the 87-kDa Protein.
Calmodulin inhibited the calcium/phospholipid-dependent phosphorylation
of the 87-kDa protein in a calmodulin-depleted preparation of rat brain
cytosol (Fig. 29).

The results are similar to those observed with a

calmodulin-depleted preparation of rat brain synaptosomal cytosol (Wu et
a l .. 1982).

This effect of calmodulin also could be demonstrated with

purified preparations of protein kinase C and the 87-kDa protein (Fig.
30) .

With calmodulin at 5 f i g / 100 f i l

was observed (Fig. 30).

(3 p M ) , an inhibition of about 80%

(This inhibition could not be explained by a

loss of free calcium due to binding to calmodulin, because calcium
was present in an excess of 167 x over calmodulin (such that the ratio
of calcium/calcium-binding site in calmodulin was 42/1).

In addition,
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Figure 29. Autoradiogram showing phosphorylation of the 87-kDa
protein by protein kinase C and its inhibition by calmodulin in a
calmodulin-depleted preparation of rat brain cytosol. The indicated
additions wg^e present in the following final concentrations: free
calcium (Ca ), 0.5 mM; phosphatidylserine (PS), 5 p g / 1 0 0 /*1; rabbit
brain calmodulin, 1 /xg/100 p i .
After termination of the phosphorylation
reaction, samples were subjected to one-dimensional NaDodSO^/6% PAGE,
followed by^iutoradiography.
87k, the 87-kDa protein; 87k(%), relative
amounts of
P found in the 87-kDa protein band for the various
conditions used. Molecular size markers are shown in kilodaltons.
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Figure 30. Representative autoradiogram showing phosphorylation
of the 87-kDa protein by protein kinase C, and its inhibition by
calmodulin, with use of purified enzyme and substrate. The experiment
was carried out five times. The indicated^additions were present in the
following concentrations: free calcium (Ca ), 0.5 mM; phosphatidylserine (PS), 5 pg/100 /*1; rabbit brain calmodulin, 5 p g/100 /xl. After
termination of the phosphorylation reaction, samples were subjected to
one-dimensional NaDodSO^/8% PAGE, followed b^2aut°tadiography.
87k, the
87-kDa protein; 87k(%), relative amounts of
P found in the 87kDa band
for the various conditions used.
Size markers are shown in kDa.
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the effect was still present when the experiment was carried out with
higher concentrations of calcium, up to 1 mM.)

Two-dimensional peptide

mapping of the 87-kDa protein after thermolysin digestion showed the
presence of the two phosphorylation sites (Fig. 31A, Chapter 2).

The

phosphorylation of both of these sites was inhibited by about 80% by the
addition of calmodulin (Fig. 31B).
Inhibition by Various Calcium-Binding Proteins of Phosnhorvlation
of the 87-kDa Protein.

The ability of brain calmodulin to inhibit the

phosphorylation of the 87-kDa protein was compared with that of several
other calcium-binding proteins, each at 5 p g / 1 0 0 p i
conditions used, parvalbumin was not inhibitory.

(Fig. 32). Under the

The phosphorylation of

the 87-kDa protein by protein kinase C was inhibited to varying extents
by the other calcium-binding proteins, the S-100 protein being
particularly potent as an inhibitor.

Thus, under the conditions used,

troponin C inhibited the phosphorylation by about 50%, brain calmodulin
and erythrocyte calmodulin each inhibited the phosphorylation by about
60%, and S-100 inhibited the phosphorylation by about 80%.

DISCUSSION

The results in this study indicated that calmodulin, troponin C,
and S-100 protein, but not parvalbumin, were able to inhibit the
phosphorylation of the 87-kDa protein by protein kinase C.

These

results and previous studies (Wu et al.. 1982) with a crude cytosol
system raised the question of whether the inhibition by calmodulin
reflected a direct or indirect action.

The ability to demonstrate the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

CALMODULIN

-

+

Figure 31. Autoradiogram showing phosphorylation of the two major
sites of the 87-kDa protein by protein kinase C, and inhibition of their
phosphorylation by calmodulin, with use of purified enzyme and
substrate. Phosphorylation was carried out in the presence of calcium
(0.5 mM free) and phosphatidylserine (5 n g / 1 0 0 ^1) and in the absence
(A) or presence (B) of calmodulin (5 /ig/100 fi 1). After termination of
the phosphorylation reaction, samples were subjected to one-dimensional
NaDodS0^/8% PAGE, followed by autoradiography. The bands of the 87-kDa
protein, located by the autoradiogram, were excised and subjected to
thermolytic digestion followed by separation in two dimensions on
cellulose plates, first by electrophoresis in the horizontal direction
(negative pole, left, positive pole, right) and then by ascending
chromatography in the vertical dimension. 0 , origin.
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Figure 32. Autoradiogram showing phosphorylation of the 87-kDa
protein by protein kinase C, and its inhibition by several calciumbinding proteins, with use of purified enzyme and substrate.
The
experiment was carried out twice. Phosphorylation was carried out in
the presence of calcium (0.5 mM free), phosphatidylserine (5 pg/100 fi 1),
and the indicated calcium-binding protein (5 jug/lOO f i l ) . After
termination of the phosphorylation reaction, samples were subjected to
one-dimensional NaDodSO^/8% PAGE, followed by autoradiography.
87k, the
87-kDa protein; PARV, parvalbumin; TnC, troponin C; BRAIN CaM, rabbit
brain calmodulin, RBC CaM, Human eryth^cyte calmodulin; S-100, S-100
protein; 87k (%), relative amounts of
P found in the 87-kDa protein
band for the various conditions used. No measurable phosphorylation was
observed in the absence of calcium plus phosphatidylserine. Molecular
size markers are shown in kilodaltons.
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effect with purified enzyme and substrate indicates that the action of
calmodulin is direct.

The concentration of calmodulin used in the

present work (3 /*M) is higher than that required to activate the
calmodulin-dependent enzymes that have the highest affinity for
calmodulin (nM range) (see Klee and Vanaman, 1982).

However, since the

concentration of calmodulin in rat brain cytosol has been calculated to
be 30 f M (Klee and Vanaman, 1982), calmodulin is present in a high
enough concentration to be a potential endogenous inhibitor of protein
kinase C.
There have been reports of inhibition by S-100 protein and
calmodulin of the phosphorylation of a 73-kDa protein, termed S-100
protein-modulated phosphoprotein, in crude supernatant fraction prepared
from brain (Patel and Marangos, 1982; Patel et al.. 1983).

On the basis

of its reported properties (Patel and Marangos, 1983), S-100 proteinmodulated phosphoprotein is probably identical to the 87-kDa protein.
Protein kinase C (see Chapter 1.) and the 87-kDa protein (Chapter
3.), are present in both neurons and glia.

Calmodulin (Sieghart et a l ..

1980) is present in neurons, and S-100 protein (Legrand et a l .. 1981) in
glial cells.

Therefore, calmodulin and S-100 protein may be acting as

physiological regulators of phosphorylation of the 87-kDa protein by
protein kinase C in neurons and glia, respectively.
kDa protein in muscle (Chapter 3).

There is little 87-

However, troponin C may inhibit the

phosphorylation of muscle-specific substrates for protein kinase C.
Thus, the phosphorylation of skeletal muscle troponin I and troponin T
by protein kinase C has been found to be inhibited by troponin C (Mazzei
and Kuo, 1984).
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Data from other laboratories have supported and extended the work
in this chapter.

Protein kinase C in human brain was found to be

inhibited by calmodulin (Saitoh and Dobkins, 1986), and calmodulin and
S-lOOb protein were found to inhibit the phosphorylation of r proteins
by protein kinase C (Baudier et a l .. 1987).

There have been a number of

studies of low molecular weight, endogenous inhibitory proteins of
protein kinase C (McDonald and Walsh 1985a,b,1986; McDonald et a l ..
1987; Schwantke and Le Peuch, 1984; Holian et al.. 1986; Hucho et a l ..
1987).

The best-studied of these is a novel M

17,000 protein which

shares many of the properties of the calcium-binding proteins (McDonald
and Walsh 1985a,b,1986; McDonald et a l .. 1987).

This protein is more

potent in inhibiting protein kinase C than any other calcium-binding
protein (McDonald and Walsh, 1985b), and has a widespread distribution
(McDonald et a l .. 1987).

In recent studies, injection of this protein

kinase C inhibitor into chick sensory neurons was able to attenuate the
norepinephrine- and OAG-induced inhibition of a calcium current (Rane et
a l . . 1987).
While these studies indicate that calcium-binding proteins can
inhibit protein kinase C, is seems that protein kinase C can also
regulate some calcium-dependent processes.

Thus, phosphorylation and

activation of the inositol trisphosphate 5'-phosphomonoesterase by
protein kinase C (Connolly et a l .. 1986) would be expected to turn off
the IP^-mediated calcium release signal.

Also, protein kinase C has

been shown to partially inhibit the actin-stimulated Mg-ATPase activity
of smooth muscle heavy meromyosin (Nishikawa et a l .. 1983), which
results from the phosphorylation of heavy meromyosin by myosin light
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chain kinase (a calcium/calmodulin-dependent protein kinase)

(Nishikawa

et a l .. 1983).
Therefore, calcium-binding protein-dependent processes and
calcium/phospholipid/diacylglycerol-dependent processes may act as
physiological modulators of each other.
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Chapter 6.

SUMMARY AND CONCLUSIONS

The studies described in this dissertation were undertaken to
analyze the role of protein kinase C in the nervous system.

Three

different approaches were employed.
First, the 87-kDa protein, a major, endogenous, specific substrate
for protein kinase C, was identified in brain, was purified from bovine
forebrain supernatant with the use of conventional chromatographic
methods, and was characterized with respect to its physicochemical
properties and distribution.

The protein was found to be very abundant

in brain, comprising 0.2% of total soluble protein.

The physicochemical

properties of the 87-kDa protein indicated that the molecular weight is
68 kDa, and that the protein is an extremely elongated monomer.

The

protein was phosphorylated by protein kinase C to a stoichiometry of 2.2
mol

32

P per mol protein, exclusively on serine residues.
The 87-kDa protein was characterized with respect to its species,

tissue, and subcellular distribution.

A similar protein was present in

monkey, human, rat, mouse, and bovine brain, in Torpedo californica
electric organ, and in a variety of non-neuronal rat and bovine tissues.
The rat protein was of M

4,000-7,000 lower, and was slightly more

acidic, than the bovine protein.

The 87-kDa protein was found to be

both cytosolic and membrane-bound, and the membrane-bound fraction may
be attached to membranes via myristoylation.

The distribution of the

125
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87-kDa protein was found to be widespread, and similar to the
distribution of protein kinase C.
While the prominence of its phosphorylation makes the 87-kDa
protein a likely candidate for a major action of protein kinase C, and
its widespread distribution makes it a candidate for an activity common
to many cells, the function of this protein has yet to be elucidated.
Based on its abundance and unusual hydrodynamic properties, one might
speculate that the 87-kDa protein is not an enzyme, but is more likely
to have a structural or regulatory function.

(One could begin to

analyze these possibilities 1) with immunocytochemistry at the electron
microscope level to localize the protein in a given cell type, before
and after treatment of the cell with activators of protein kinase C , and
2) with biochemical studies of interactions between the dephospho- and
phosphoprotein and other proteins of known structural function, e.g.
cytoskeletal proteins.)

Alternatively, since two other endogenous

substrates for protein kinase C have been postulated to regulate steps
in PI turnover (see Chapter 2), one might also postulate a role for the
87-kDa protein in the feedback regulation of PI turnover.

Evidently, a

role for this protein should be sought among the known actions of
protein kinase C, such as secretion, modulation of membrane functions,
feedback inhibition of receptor systems, and interactions between
signaling systems (see Chapter 1).

Further characterization of this 87-

kDa protein, a major endogenous substrate for protein kinase C, will
undoubtedly provide information about the actions of protein kinase C at
the molecular level.
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Second, the effect of phosphorylation by protein kinase C was
examined with a nervous system protein of known function, namely
tyrosine hydroxylase.

Protein kinase C was found to phosphorylate and

activate tyrosine hydroxylase.

The data support the possibility that

protein kinase C is a physiological activator of tyrosine hydroxylase in
response to stimulation of PI turnover, and thereby acts to accelerate
catecholamine biosynthesis.
Third, the regulation of protein kinase C activity by calciumbinding proteins was examined.

It was found that certain calcium-

binding proteins inhibit protein kinase C activity.

This finding

constitutes an example of a means by which the two second messengers
generated from PI turnover, IP^ and diacylglycerol, may regulate each
other.

Thus, as PIP2 is hydrolyzed into IP^ and diacylglycerol, signals

for calcium release from intracellular stores and for the activation of
protein kinase C, respectively, are generated (Fig. 33).

The calcium

released from the intracellular stores may bind to calcium-binding
proteins and inhibit protein kinase C.

Meanwhile, protein kinase C may

phosphorylate and activate the IP^-S'-phosphomonoesterase (Connolly et
a l .. 1986; Molina y Vedia et al.. 1986), thereby terminating the signal
to release calcium.
More generally, calcium-dependent processes and protein kinase Cdependent processes may modulate each other.

In the nervous system,

calcium activates the phosphoinositidase responsible for PIP2 hydrolysis
(see Fisher and Agranoff, 1987).

Activation of protein kinase C seems

to cause a decrease in cytosolic calcium concentration, which has been
postulated to be caused by activation of a calcium-ATPase (see
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Figure 33. Feedback interactions between protein kinase C and
calcium. As PIP- is hydrolyzed into IP, and diacylglycerol, signals for
calcium release from intracellular stores and for the activation of
protein kinase C, respectively, are generated.
The calcium released
from the intracellular stores may bind to calcium-binding proteins and
inhibit protein kinase C. Meanwhile, protein kinase C may phosphorylate
and activate the IP^-S'-phosphomonoesterase, thereby terminating the
signal to release calcium.
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Nishizuka, 1986).

In injection experiments, protein kinase C has been

found to modulate calcium currents and calcium-dependent potassium
currents (see Chapter 1).

Calcium and protein kinase C also cooperate

to cause secretion (see Chapter 1).
Further characterization of the substrates for protein kinase C,
and of the interactions between protein kinase C-dependent and calciumdependent processes, will undoubtedly provide further information at the
molecular level about the actions of protein kinase C in the nervous
system.
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